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ABSTRACT  
The right to health is a fundamental human right, medications constitute a vital component 
of any health system worldwide. Hence, access to medicines is one entitlement of the right to 
health, and governments pay increasing concerns to improve equitable access to healthcare and 
medications among all citizens. Egypt is a middle income country, with tight resources and 
capabilities to spend on health, and a pluralistic and fragmented healthcare system. Therefore, 
aggravated challenges are facing the government towards the achievement of the “Health for all” 
constitutional right. Identifying where inequalities exist, and monitoring their change over time, is 
a major prerequisite towards creating an equity-oriented health sector. Therefore, Egypt Health 
Issues Survey from 2015 was used to assess the situation of equitable access to healthcare as 
represented in treating the Non Communicable Diseases, and to gauge the extent to which the 
different socio-economic determinants impact access to medications among NCD patients. 
Only 69.2% of the population of NCD patients in the age range (15-59 years) have a 
complete access to NCD treatment, while the other 30.8% have incomplete access to treatment. 
Irrespective of age, gender, place of residence, income, education, marital and employment status, 
private facilities were the provider of choice, for receiving NCD(s) care and treatment. Hence, 
NCD patients incur higher financial burden; the average out-of-pocket spending on treatment in a 
private health care facility is 3.5 times more than in a governmental healthcare facility. 
NCD treatment is an essential treatment that should be accessible for all patients 
irrespective of their age, sex, place of residence, economic status, etc. However, significant 
inequalities in accessing NCD treatment were detected among the different social groups, where 
complete access to NCD treatment is skewed against the poor, young-aged, males and those living 
outside Urban Governorates. Inequalities in the different socioeconomic factors impacted the 
inequality in accessing treatment with varying degrees; the main determinant is wealth, responsible 
for over 90% of the detected inequality; followed by education, age, and type of place of residence.  
Generally, policymakers should work on improving the overall population access to NCD 
treatment through improving medications availability and affordability at both private and 
governmental healthcare facilities, and special programs should target underprivileged groups. The 
results and inequality data generated from this research should provide a foundation for 
incorporating equity into evidence-based health planning, and also assessing whether current 
health initiatives promote equity in accessing treatment. 
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Definition of Key Terms and Concepts: 
 
Ø Non-Communicable Disease (NCD): 
• A wide group of medical conditions, or diseases that are, by definition, non-infectious and 
non-transmissible among people”  
• For the purposes of this study, NCD represent the presence of one or more of the following 
diseases: Hypertension, Diabetes, Heart attack, and/ or Stroke. 
 
Ø Access to treatment: 
• The individual is taking prescribed medication (s) for his/her condition “disease” 
• For the purpose of this study, ‘access’ to NCD treatment refers to complete access of 
treatment, in other words, receiving prescribed medication(s) for all identified NCDs; and ‘in-
access’ refers to either partial or complete in-access to treatment, in other words, having at 
least one NCD identified and not being treated. 
 
Ø Out-of-pocket spending: 
• Out-of-pocket spending or payments (OOPs), according to the WHO, are defined as direct 
payments made by individuals to health care providers at the time of service use [46]. 
• For the purpose of this study, Out-of-pocket spending refers to the overall money spent for 
care/treatment for the condition being diagnosed in the past four weeks. This include all costs 
for consultation, examination, medication, tests, and other treatment received. 
 
Ø Total Healthcare Spending 
• Health spending, according to the OECD, measures the final consumption of health care goods 
and services (i.e. current health expenditure) including personal health care (curative care, 
rehabilitative care, long-term care, ancillary services and medical goods) and collective 
services (prevention and public health services as well as health administration), but excluding 
spending on investments. This indicator is presented as a total and by type of financing 
(“public”, “private”, “out-of-pocket”) and is measured as a share of GDP, as a share of total 
health spending and in USD per capita (using economy-wide PPPs) [47]. 
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1 
I. Introduction 
 
Background: 
The right to health is a fundamental human right that was first articulated in the 1964 
Constitution of the World Health Organization (WHO), whose preamble described that “the 
enjoyment of the highest attainable standard of physical and mental health is one of the 
fundamental rights of every human being without distinction of race, religion, political belief, 
economic or social condition” [1].  
Medicines are vital component of any health system worldwide. Hence, “access to essential 
medicines is one entitlement of the right to health” [1]. Therefore, ensuring accessibility of 
affordable, effective and safe medications is a critical public policy goal considered by every 
country. Moreover, it is a principle that has been echoed in the recently adopted 2030 Agenda for 
Sustainable Development Goals; “Goal 3.8. achieve universal health coverage, including financial 
risk protection, access to quality essential health-care services and access to safe, effective, quality 
and affordable essential medicines and vaccines for all” [2]. 
Governments pay increasing concerns to improve equitable access to healthcare and 
medications among all citizens regardless their age, gender, income level, educational status, 
geographic location, etc. However, considerable disparities and inequities still exist especially in 
low and middle income countries whose resources to spend on health is tight, such as Egypt. 
Therefore, this research assesses the extent to which the different socio-economic determinants 
impact access to medications and seeking treatment among patients of non-communicable diseases 
in Egypt.  
Context: 
Egypt is a middle income country, and its resources and capabilities to spend on health 
have been evaluated to be very tight. In 2014, total healthcare spending in Egypt was 5.642% of 
GDP, compared to 5.8% of GDP in middle income countries, and to 12.3% of GDP spending in 
high income countries [3].  
The healthcare system in Egypt has been described to be “fragmented with multiple service 
providers, with the The Ministry of Health and Population (MOHP) lies at the center as the main 
service provider” [4]. Services are delivered through different establishments managed and 
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overseen by the MOHP, such as public hospitals, university hospitals and hospitals belonging to 
the Health Insurance Organization (HIO), which is the public health insurance system. The 
coverage of HIO, however, is limited to about 58% of the population and covers only employees 
of the public sector [5]. Health services in the governmental facilities, including medicines, are 
provided either for free or against a small fee. Those who do not have insurance coverage can 
benefit from the Program for Treatment at the Expense of the State, which was initiated by the 
government with an independent budget [4].  
The public expenditure on health, in 2014, represented only 38.2% of the total expenditure 
on health, compared to 51.95% in middle income countries, and 62.3% in high income countries 
[3]. The low public spending on health is coupled with high private and out-of-pocket spending; 
in 2014, the out-of-pocket spending in Egypt was estimated to be 55.66% of the total healthcare 
expenditure, compared to 36.2% in middle income countries, and 90% of the private expenditure 
on health, compared to 75.3% in middle income countries (Ibid). Table (1) shows both the 
healthcare spending, as a percentage of GDP; and the percent of public and out-of-pocket spending 
on health, in Egypt compared to average middle and high income countries in 2014. 
 
 
 
 
 
 
 
All these factors, combined, are putting aggravated challenges on the average citizen 
(patient). In Egypt, in 2012/2013, medications were estimated to account for 53% of total 
healthcare expenditure, while, on average, “pharmaceuticals account for about a fifth of total 
health care expenditure” [6, 7]. 
Justification:  
Health for all is a constitutional right and a main objective of the Egyptian government. 
“The Ministry of Health and Population (MOHP) has placed high priority on achieving this 
Table 1 The Healthcare Spending, as a percentage of GDP, 2014 
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objective, developing a national system of health facilities providing services at all levels” [8]. 
Moreover, the MOHP consider itself, continuously, committed to increasing the quality and 
coverage of the health care system.  
However, given, the current context of the Egyptian healthcare system, and the patterns of 
spending on healthcare, where, the government has been trying to improve access to healthcare by 
increasing the spending on healthcare (health expenditure per capita), and faced by the tight 
resources and increasing demands (public expenditure on health as a percentage of government 
expenditure), the government and policy makers have been facing an aggravated pressure to set 
the health and pharmaceutical policies and regulations that ensure equitable access to health and 
medications and better targeting the less privileged who cannot afford out-of-pocket spending. 
Figure (1) illustrates the health expenditure in Egypt over the period from 2000 to 2014; both the 
health expenditure per capita in US$ and the expenditure on health as a percentage of government 
expenditure. 
 
 
 
 
 
 
 
 
 
 
 
According to the WHO, “a necessary prerequisite to creating an equity-oriented health 
sector is to systematically identify where inequalities exist, and, then, monitor how inequalities 
change over time” [9]. The improved health inequality monitoring in low- and middle-income 
countries, such as Egypt, is “a critical and timely priority to ensure the betterment of health across 
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Figure 1 Health Expenditure in Egypt (2000-2014) 
Source: World Bank, 2016 
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all members of society, especially the most disadvantaged” [Ibid]. Therefore, it will be of 
significant value to assess the situation of equitable access to healthcare as represented in treating 
the Non Communicable Diseases (NCDs), and to gauge the extent to which the different socio-
economic determinants impact access to medications and seeking treatment among this category 
of patients given the Egyptian context. The results and inequality data generated from this research 
should provide a foundation for incorporating equity into evidence-based health planning, and also 
assessing whether current health initiatives promote equity in accessing treatment. 
NCDs were chosen as they are among the leading causes of death in Egypt. According to 
the WHO Progress Monitor, the percentage of deaths from NCDs in Egypt is 83%, with a total 
number of 476,000 NCDs death out of a population of 93,778,000 in 2015. The estimated risk of 
pre-mature death from a NCD in Egypt is 24% [17]. NCD medications are essential medicines, 
and wide range of their different classes and categories is registered, marketed in the private sector, 
and procured via the National Tendering System to the different public healthcare facilities in 
Egypt.  
Goal, Aim and Objectives  
The goal of this study is to better guide policy and decision makers about the degree of 
inequalities existing in accessing and affording treatment and medications in Egypt. The evidence 
generated from the study will contribute to better-informed policies, programs and practices, that 
can improve the government’s strategy towards a universal equitable healthcare coverage. 
This study aims at analyzing the EHIS 2015 health survey data in order to measure the 
extent to which the different socio-economic determinants impact equitable access to treatment for 
the non-communicable diseases, mainly: high blood pressure, diabetes and cardiovascular diseases 
(stroke, heart attack, etc.).  
 The study should fulfill the following objectives: 
1. Estimate the percentage of NCDs’ patients in Egypt who did not receive (have full access 
to) treatment for their diseases versus those who have full access. 
2. Gauge the accessibility and affordability of medications based on (a) whether patients 
receive treatment for their diagnosed NCD condition or not, (b) whether treatment is sought 
at a public versus private healthcare facility, and (c) the average monthly out-of-pocket 
spending on NCDs in Egypt. 
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3. Assess the level of equality versus inequality among NCDs’ patient for accessing 
treatment. 
4. Explore the different socio-economic determinants impacting inequality in accessing NCD 
treatment, and estimating the impact of each factor (determinant) towards the observed 
inequality in NCD treatment. 
Research Questions:  
Main Question: “To what extent do the different socio-economic determinants impact the equitable 
access to treatment for the NCDs in Egypt?”  
Sub-question (1): What is the proportion of Egyptian patients who access, versus those how did 
not access, treatment for their NCDs? 
Sub-question (2): What are the relative percentage and characteristics of Egyptian patients with 
NCDs who receive treatment for NCDs in public versus private healthcare facilities? 
Sub-question (3): How much did the NCD patient spends, on average, out-of-pocket on 
treatment? 
Sub-question (4): What are the main socio-economic determinants impacting the access to 
treatment? 
Sub-question (5): To what extent does the different socio-economic determinants contributes to 
the inequality in accessing affordable treatment for NCDs? 
 
II. Literature Review 
 
The NCDs, or the Non Communicable Diseases, are non-infectious and non-transmissible 
diseases. The prevalence of NCDs has increased significantly for a variety of reasons including 
population ageing and increased exposure to risk factors such as tobacco use, physical inactivity, 
and unhealthy diets [11, 12]. Additionally, their burden in low and middle income countries is 
growing particularly fast during the last two decades [13]. Therefore, the importance of NCDs for 
global health has gained an increased recognition; and has been accompanied by calls for a stronger 
policy response. Global stakeholders have signaled a commitment to confronting the growing 
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burden of NCDs by including them in the Sustainable Development Goals (SDGs), where 
increasing access to essential NCD medicines is a fundamental part of these efforts [14-16]. 
Several dimensions need to be explored in any discussion related to the NCDs, mainly: 
their prevalence, burden, needed interventions, and the equity perspective, as will be explored in 
the following sections. 
Non Communicable Diseases: Prevalence and Risk Factors 
A non-communicable disease (NCD) is “a medical condition or disease that is by definition 
non-infectious and non-transmissible among people” [17]. NCDs are of long duration and are the 
result of a combination of genetic, physiological, environmental and behavioral factors. The main 
types of NCDs include: cardiovascular diseases (heart attacks and stroke), cancer, chronic 
respiratory diseases (chronic obstructive pulmonary disease and asthma), and diabetes [Ibid]. 
Chronic non-communicable diseases (CNCDs) are reaching epidemic proportions 
worldwide [14, 18, 19]. They affect people of all ages, nationalities, and classes. Therefore, NCDs 
will continue to dominate health care needs in most low- and middle-income countries [14, 18]. 
Tobacco use, physical inactivity, the harmful use of alcohol and unhealthy diets all increase the 
risk of dying from a NCD. Additionally, these diseases are driven by forces that include rapid 
unplanned urbanization, globalization of unhealthy lifestyles and population ageing [11, 12, 20]. 
Different studies and population-based surveys have revealed that in Egypt, there is a 
significantly high prevalence of risk factors for NCDs among the adult population. The 2011/2012 
MOHP and WHO STEPwise survey revealed a 24% prevalence of smoking and a growing use of 
shisha tobacco; 66% of women in Egypt were overweight, 42% were obese, and almost three 
quarters of the population were not involved in vigorous activity; a 17% prevalence of diabetes 
and a 40% prevalence of hypertension [21]. The more recent Health Issues Survey (2015) also 
revealed that, among individual aged 15-59, almost half of men (46%) are current smokers of 
cigarettes or other tobacco products, but very few women reported smoking (0.2%); around 3 in 4 
women and 6 in 10 men are overweight or obese; and around 1 in 6 women and men were classified 
as hypertensive (hypertension prevalence is 17.2% for women and 16.7% for men) [8]. 
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Burden of NCDs: Mortality, Morbidity, and Economic Burden 
As argued earlier, the importance of non-communicable diseases (NCDs) for global health 
has gained increased recognition since the early 1990s, such importance stemmed from the 
increased prevalence of NCDs and their epidemic widespread even in low and middle income 
countries; and, more importantly, the burden of NCDs on both the national and global level, which 
puts it on the top of the priorities of the national public policies and the global health agenda. 
The premature death from NCDs continues to be one of the major development challenges 
in the 21st century. According to the WHO Progress Monitor (2017), NCDs cause the greatest 
global share of death and disability, responsible for around 70% of all deaths worldwide; 
approximately 40 million people each year. The number of deaths from these diseases is double 
the number of deaths that result from a combination of infectious diseases (including HIV/AIDS, 
tuberculosis and malaria), maternal and perinatal conditions, and nutritional deficiencies [17].  
Such a burden leaves no country untouched; and is rising disproportionately among low- 
and lower-middle-income countries, where almost half of premature NCD deaths occur and, even, 
projected to rise [13, 17, 18]. In Egypt, the percentage of deaths from NCDs in Egypt is 83%, with 
a total number of 476,000 NCDs death out of a population of 93,778,000 in 2015. The estimated 
risk of pre-mature death from a NCD in Egypt is 24% [17]. 
Different studies tried to asses the economic burden of NCDs. Engelgau et. al. (2011) 
argued that NCD short- and long-term disability can lead to a decrease in working-age population 
participation in the labor force and reduce productivity and, in turn, reduce per capita gross 
domestic product growth [22]. In the context of enormous global health spending, serious concerns 
about already strained public finances and lackluster economic growth are also rising [Ibid]. 
Bloom et. al. (2011) tried to estimate the global economic burden of NCDs in 2010, and to 
project the size of the burden though 2030, using three distinct approaches; the standard cost of 
illness method, the macroeconomic simulation, and the value of a statistical life. With respect to 
cardiovascular disease, chronic respiratory disease, cancer, diabetes, and mental health, the study 
estimated “a cumulative output loss of US$ 47 trillion over the next two decades. This loss 
represents 75% of global GDP in 2010 (US$ 63 trillion). It also represents enough money to 
eradicate two dollar-a-day poverty among the 2.5 billion people in that state for more than half a 
century” [23]. 
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Although high-income countries used to bear the biggest economic burden of NCDs, “the 
developing world, especially middle-income countries, is expected to assume an ever larger share 
as their economies and populations grow” [23]. In a low-resource settings, the different costs of 
NCDs, including often lengthy and expensive treatment and loss of breadwinners, force millions 
of people into poverty annually and, hence, curb development [17]. Therefore, the current 
economic burden of NCDs is enormous, and it is expected to continue staggering over the next 
two decades [23].  
Tackling NCDs: Diagnosis, Availability and Accessibility of Treatment 
Governments have made many political commitments to prevent and control NCDs. In 
addition, global stakeholders and world leaders have signaled a commitment to confront the 
growing burden of NCDs by including them in the Sustainable Development Goals, with 
increasing the access to essential NCD medicines as a fundamental part of these efforts [2, 15, 17]. 
Children, adults and the elderly are all vulnerable to the risk factors contributing to NCDs, 
whether from unhealthy diets, physical inactivity, exposure to tobacco smoke or the harmful use 
of alcohol. Hence, focusing on reducing the risk factors associated with NCDs is an important way 
to control these diseases. Therefore, the WHO is, continuously, calling for a comprehensive 
approach covering all sectors including health, finance, transport, education, agriculture, planning 
and others, to collaborate to reduce the risks associated with NCDs, and promote interventions to 
prevent and control them [17]. Additionally, given the prevalence and burden of NCDs, the WHO 
has reflected on the critical importance of investing in better management including: detecting, 
screening and treating these diseases, and providing access to palliative care for people in need. 
The WHO evidence shows that “such interventions are excellent economic investments because, 
if provided early to patients, they can reduce the need for more expensive treatment” [20].  
The Global Action Plan, developed by the WHO, includes a voluntary medicines target of 
80% availability and affordability of essential medicines for the prevention and treatment of 
diabetes, cardiovascular disease and respiratory disease both in public and private health facilities 
[24]. Moreover, according to the WHO Progress Monitor (2017), “different member states should 
have evidence-based national guidelines, protocols, and/ or standards for the management of major 
NCDs through a primary care approach. Additionally, they should provide drug therapy, including 
glycemic control, and counselling for eligible persons at high risk to prevent heart attacks and 
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strokes, with emphasis on the primary care level” [17].  
Despite the collaborated efforts, many countries still face challenges with the availability 
and affordability of different essential NCD treatment. The findings of the Prospective Urban 
Rural Epidemiological (PURE) study—a large international cohort study of more than 150,000 
individuals, living in 626 communities— have highlighted that “the availability and affordability 
of blood pressure-lowering medicines was particularly low in low-income countries, where only 
13% (nine of 68) of community retail pharmacies had four blood pressure-lowering medicines 
available; in high-income countries, 94% (108 of 115) of communities had four drug classes 
available. Besides, 30% of households in low-income countries could not afford multiple blood 
pressure-lowering medicines, and this rose to more than 75% when statins were included” [24]. 
Moreover, different studies have reported an unacceptably worldwide low availability of 
medicines for non-communicable disease treatment, and a particular suboptimal availability of 
NCD medicines in developing and low income countries [25 - 29].  
The mean availability of essential medicines in 36 low- and middle-income countries was 
about 36% for NCDs versus 54% for acute diseases in the public sector, and 55% versus 66% (but 
at a much higher price) in the private sector. The probability of patients receiving at least one 
medicine for secondary prevention of cardio- vascular disease was 19.8% in low-income countries, 
30.7% in low-income and middle-income countries, and 54.9% for upper-middle-income countries 
[15, 37]. 
An Equity Perspective towards NCDs and their Management 
While individuals from different backgrounds, social groups, and countries enjoy different 
levels of health, it is always important to distinguish between the unavoidable health inequalities 
and unjust and preventable health inequities [35].  
It is highly argued that the NCD epidemic is driven by poverty, globalization of marketing 
and trade of health-harming products, rapid urbanization, and population growth. Hence, NCDs 
disproportionally affect the poorest and those furthest behind [20, 30]. In the context of tackling 
NCDs, the challenge “lies in countries with inadequate health insurance coverage, as they are 
unlikely to provide universal access to essential NCD interventions” [9]. Additionally, De 
Maeseneer, et. al., (2012) argued that “social determinants—in particular, inequities in education 
and income must be addressed alongside the development of an effective health-care delivery 
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system that integrates personal and community care” [31]. 
In Egypt, different studies highlighted the inadequate health insurance coverage and the 
disproportionate utilization of governmental health services by the poor. Based on the 2005 Social 
Contract Survey Data, Shawky, S (2010) found out that “only 22.8% of the population in the 
productive age range (19-59 years) benefited from any health insurance scheme” [36]. 
Additionally, “the employment-based insurance scheme, which is the dominant scheme targeting 
the productive population, covered 39.3% of the working population and was skewed towards 
urban areas, older people, females, and the wealthier. It didn’t increase service utilization, but 
reduced out-of-pocket spending” [Ibid].  
Furthermore, Nandakumar AK, Chawla M, Khan M (2000) and Rashad, AS & Sharaf, MF 
(2015) analyzed the utilization of health care services by the poor in Egypt. They found that “even 
though the government provides free care, a significant proportion of the poor visit fee-for-service 
private providers. As a result, the poor and the indigent spend disproportionately larger amounts 
on health compared to the rich” [41]. Rashad, AS & Sharaf, MF (2015) argued further that health 
care subsidies in Egypt are pro-rich and have inequality increasing effect. Therefore, they 
recommended that “healthcare reforms in Egypt should not only focus on expanding the coverage 
of healthcare benefits, but also on improving the equity of its distribution” [43].  
In conclusion, NCDs are driven by a combination of genetic, physiological, environmental 
and behavioral factors. Individuals at all ages are vulnerable to the risk factors contributing to 
NCDs. These group of diseases have high prevalence; they are reaching epidemic proportions 
worldwide. NCDs have high social and economic burden, which is rising disproportionately 
among low –and middle- income countries. Therefore, it is critical to invest in better management 
and equally providing access to all needed interventions among the different socio-economic 
determinants in the society. As recommended by the WHO, “an equity perspective will be of added 
value” and “a necessary prerequisite to creating an equity-oriented health sector is to 
systematically identify where inequalities exist, and then monitor how [these] inequalities change 
over time” [9] The focus of this study is to assess the extent to which the different socio-economic 
determinants impact equitable access to NCDs treatment in Egypt, mainly: high blood pressure, 
diabetes and cardiovascular disease (stroke and heart attack). 
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III. Conceptual framework  
 
The study is based on the WHO (2010) conceptual framework of the “Social Determinants 
of Health, (SDH)” which serves two equally important purposes: first, it guides the empirical work 
to enhance our understanding of determinants and mechanisms of health outcomes, and, second, 
it guides policy-making to illuminate entry points for interventions and policies. According to the 
CSDH, and as illustrated in figure (2), “populations are stratified according to income, education, 
occupation, gender, race/ethnicity and other factors; these socioeconomic positions in turn shape 
specific determinants of health status (intermediary determinants) reflective of people’s place 
within social hierarchies; based on their respective social status, individuals experience differences 
in exposure and vulnerability to health-compromising conditions” [32].  
The framework also reflects the underlying structural determinants or mechanisms, which 
are rooted in the key institutions and processes of the socioeconomic and political contexts that 
generate and maintain social hierarchies, mainly: the labor market, the educational system, some 
political institutions, cultural and societal values, and, most importantly, the welfare state and its 
redistributive policies (or the absence of such policies).  
 
 (Source: WHO, 2010) 
Figure 2 "Conceptual Framework of the Social Determinants of Health 
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IV. Methods		
Research Type and Study Design  
This research is a quantitative analysis. It is an observational cross-sectional study; that 
covers both descriptive and analytical aspects.  
Source of Data   
The study made use of a secondary data, which is the individual level, Egypt Health Issues 
Survey Data (EHIS) from 2015 [8]. The sample was designed to be a representative sample that 
can provide estimates of all major variables at the national and regional level. The main objective 
of the sample was to provide the Ministry of Health and Population (MOHP) with a rich body of 
data that can be used to improve the delivery of health care services in Egypt. The primary focus 
of the EHIS was to obtain information on the awareness and prevalence of hepatitis, and the 
proportion of respondents who had been diagnosed and were being treated for non-communicable 
diseases such as: diabetes, heart attack, and stroke [8].  
Sampling Technique   
The survey was conducted in Egypt, where the field work lasted for three months starting 
at February to May 2015. The EHIS used a sub-sample of 614 primary sampling units (PSUs) 
selected from the a total of 842 PSUs, from the different administrative regions covering the 25 
governorates. The frame for selection of these units was a list of all shiakhas and villages, obtained 
from the Central Agency for Public Mobilization and Statistics (CAPMAS) [8]. Therefore, the 
survey was designed to generate a nationally representative sample, where the governorates and 
households were selected to cover diverse geographic locations and varying socio-economic levels 
across Egypt1.  
Study Population and Sample  
The target study population is the Egyptian patients, age from 15 to 59 years old, with one 
or more NCDs. Therefore, the inclusion criteria among individuals surveyed in the (EHIS, 2015) 
is that an individual has been told by a doctor or other health professional that he had (1) 
hypertension or high blood pressure, (2) diabetes (other than during pregnancy), (3) heart attack 
                                                
1 More details about sampling and data are available on DHS website (https://dhsprogram.com)  
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or myocardial infarction, or (4) stroke. Additionally, for hypertension, respondents with average 
systolic and diastolic pressure measurements greater than or equal to 140/90 were considered to 
be hypertensive.2 In addition, respondent were considered to be hypertensive if they had a normal 
or optimal blood pressure reading but were taking medication to lower their blood pressure. 
The total sample of individuals, aged from 15-59 years, in EHIS 2015, is 16,671 (9,209 
women & 7,422 men). Based on the selection criteria the study sample is 2,115 individuals with 
one or more NCDs (1,313 women & 802 men), compared to 14,556 who don’t have any (7,896 
women & 6,660 men). 
Data and Variables 
The survey data included socio-demographic information; age, sex, education, marital 
status, wealth index (wealth quintiles), employment, place of residence (type and governorate), 
etc. It contains data on whether a respondent has been told by a doctor or other health professional 
that he/she had hypertension, diabetes, heart attack or myocardial infarction, or stroke. Also, 
information on measurements and categories of hypertension is available. Therefore, these four 
NCDs will be used as proxy indicators for NCDs. 
The available information was used to 
define new variables; an indicator variable of 
whether a respondent has NCD or not, and a 
scale variable reporting the number of NCDs of 
each respondent. Based on the EHIS, 2015 
sample, individuals with NCDs might have one, 
two, three, or four NCDs. Table (2) shows the 
percent of individuals in each category. The 
basic background characteristics of the sample 
with regard to NCDs is shown in Table (3). 
 
                                                
2 The cutoff for high blood pressure reflects the classification currently used by WHO (2014) in its global reporting 
as cited in (Ministry of Health and Population [MOHP], Elzanaty & ICF International, 2015, P. 74). 
Table 2 Non-Communicable Diseases, Prevalence 
and Numbers, EHIS 2015 
Socio-economic Inequalities in Accessing Treatment of NCDs, EHIS 2015          14 
 Table 3 Basic Background Characteristics of Individuals with regard to NCDs, EHIS 2015 
<29 7,185       (43.1) 7,002   (48.1) 183     (8.7)     
30-39 4,102       (24.6) 3,784   (26.0) 318     (15.0)   
40-49 2,933       (17.6) 2,333   (16.0) 600     (28.4)   
50-59 2,451       (14.7) 1,437   (9.9)   1,014  (47.9)   
Male 7,462       (44.8) 6,660   (45.8) 802     (37.9)   
Female 9,209       (55.2) 7,896   (54.2) 1,313  (62.1)   
Urban 8,196       (49.2) 6,987   (48.0) 1,209  (57.2)   
Rural 8,475       (50.8) 7,569   (52.0) 906     (42.8)   
Urban governorates^ 3,007       (18.0) 2,539   (17.4) 468     (22.1)   
Urban lower Egypt 2,098       (12.6) 1,764   (12.1) 334     (15.8)   
Rural lower Egypt 4,072       (24.4) 3,581   (24.6) 491     (23.2)   
Urban upper Egypt 2,326       (14.0) 2,005   (13.8) 321     (15.2)   
Rural upper Egypt 4,144       (24.9) 3,750   (25.8) 394     (18.6)   
Frontier Governorates 1,024       (6.1)   917      (6.3)   107     (5.1)     
Q1 (poorest) 3,428       (20.6) 3,103   (21.3) 325     (15.4)   
Q2 2,841       (17.0) 2,506   (17.2) 335     (15.8)   
Q3 2,340       (14.0) 2,082   (14.3) 258     (12.2)   
Q4 3,629       (21.8) 3,160   (21.7) 469     (22.2)   
Q5 (richest) 4,433       (26.6) 3,705   (25.5) 728     (34.4)   
No education  2,468       (14.8) 1,965   (13.5) 503     (23.8)   
Some primary 2,086       (12.5) 1,692   (11.6) 394     (18.6)   
Primary complete/ some secondary 9,486       (56.9) 8,579   (58.9) 907     (42.9)   
Secondary complete/ higher 2,631       (15.8) 2,320   (15.9) 311     (14.7)   
Never married 4,547       (27.3) 4,453   (30.6) 94       (4.4)     
Ever married 12,124     (72.7) 10,103 (69.4) 2,021  (95.6)   
Not Employed 9,102       (54.6) 7,965   (54.7) 1,137  (53.8)   
Employed 7,569       (45.4) 6,591   (45.3) 978     (46.2)   
*** p < 0.001
^ Cairo, Alex, PortSaid, and Suez
Variable
Total
Individuals  
without NCD
Individuals  
with NCD
n=16,671 n=14,556 n= 2,115
Age (years)***
Sex***
Type of place of residence***
Region***
Wealth quintiles***
Education***
Marital status***
Employment status
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The survey data, also, included information on whether the respondent receives 
treatment/medication(s) for the reported NCDs. Therefore, among NCD patients, access to 
treatment to the four reported NCDs will be used as a proxy indicator to access to NCD(s) 
treatment. The available information was used to define new variables; a scale variable calculating 
the percentage of treated NCD(s) to the number of identified NCD(s). The variable was, then used 
to classify each respondent as either having a full access to NCD treatment (those with 100% 
coverage); or having incomplete access to NCD treatment (those with coverage less than 100%), 
this variable will be the main dependent variable and equity indicator during the analysis. The 
rationale behind this classification is that a single condition with in-access to treatment is reflected 
into an individual with in-access to treatment.  
Finally, the survey data contained some information on whether the respondent is receiving 
care for the reported NCD(s) in a governmental or private health care facility, and the out-of-
pocket spending (total cost) on the reported NCD(s) during the last four weeks, which can be used 
to estimate the average monthly out-of-pocket spending on NCD(s). For the majority of the 
variables, almost all the records had complete information (98%); for the last two variables, the 
facility of receiving care and the out-of-pocket spending, the majority of the records (87%) had 
complete information, and, therefore, can be used for the analysis. 
Appendix (1) illustrates the variables used in the analysis and some information regarding 
their corresponding (original) variables in the EHIS, 2015 dataset. 
Data Analysis 
The data were weighted to give estimates that were representative of the population from 
which the sample was drawn. The data analysis was done to mirror the conceptual framework, 
where the study estimated the impact of the different socio-economic factors (stratifiers) on 
accessing treatment, and the level of out-of-pocket spending on the NCDs. For all the analyses, 
the chi-squared test was used detect significant differences between proportions, t-test and 
ANOVA were used to detect significant differences between means.  
The impact of the different socio-economic factors on accessing3 NCD treatment, and the 
level of incurred financial burden born by individuals was measured using a 2-parts model. Part 1 
                                                
3 For the purpose of this study, ‘access’ to NCD treatment refers to complete access of treatment, and ‘in-access’ refers to either 
partial or complete in-access to treatment. 
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is a logit model estimating the individual’s probability of completely accessing NCD treatments. 
Part 2 is a linear model that estimated the average monthly out of pocket spending by a patient 
when having a complete access to NCD treatments. 
For inequality measurements, since inequality is a complex and ambiguous concept that 
can be measured and conveyed using a variety of statistical techniques [9], and with the goal to 
provide a quantitative estimate of inequality in accessing treatment among Egyptian NCD patients, 
a variety of measures were calculated to fully explore the situation.  
Simple (gap) measures of inequality were, preliminary, assessed; the absolute inequality 
reflected the magnitude of difference between the dichotomous subgroups, and the relative 
inequality showed the proportional differences among subgroups. Then, the analysis computed the 
complex (gradient) measures of inequality, which, significantly, contribute to the inequality 
picture by considering all subgroups and taking into consideration the relative size of each 
subgroup. First, complex measures relying on the prevalence was calculated; Population 
Attributable Risk (PAR and PAR%), the Mean Deviation (MD), Standard Deviation (SD), and, 
their, Weighted and Relative Measures, and the Slope Index of Inequality (SII). Second, complex 
measures relying on the distribution were calculated; Index of Dissimilarity (ID & ID%), Theil 
Index (TI), and the Concentration Index (CI).  
Finally, a decomposition analysis was done to estimate how determinants proportionally 
contribute to inequality in the ‘in-access to NCD treatment’ health variable Therefore, the 
concentration index was decomposed into its main socio-economic determinants [33, 34]. 
Computer Package(s) 
IBM Statistics, version 23, computer package was used for all data analyses. STATA, 
version 12, computer package was used for the calculations of Concentration Index (CI). 
Additionally, some inequality measures were calculated using Microsoft Excel, 2010.  
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V. Results: 
Characteristics of the Study Sample 
A total of 2,115 individuals in the working age range (between 15 and 59 years) were 
included in the study. On the national level, 30.8% of NCD patients have incomplete access to 
NCD treatment. A higher proportion of those with incomplete access to NCDs treatment was 
among individuals aging from 50-59 years old, 34.3%. Additionally, 43% of patients with 
incomplete access to NCDs treatment are those with Primary Educational level and 28.1% of them 
are living in Rural Upper Egypt governorates. 
As a proportion of those with incomplete access to NCDs treatment; females were slightly 
higher (54.4%) than males, rural areas (50.8%) were higher than urban areas, and, surprisingly, 
employed individuals (51.6%) were higher than non employed ones. The distribution of 
individuals with incomplete access to NCDs treatment across the wealth quintiles shows lower 
proportions among middle classes (19.6%, 11.7%, 19.8% for the second, third, and fourth wealth 
quintiles respectively), compared to the two extreme quintile (21.4% and 27.5% for the first and 
fifth wealth quintiles). Table (4) shows the background characteristics of the study sample. 
Among NCD patients, individuals who have complete access to NCD treatment, might 
receive care and treatments for their NCD(s) in governmental (11.6%), private (72.8%), or both 
governmental and private healthcare facility (15.6%). Private facilities were the provider of choice 
irrespective of age, gender, place of residence, income, education, marital and employment status.  
Access to NCD Treatments and Financial Burden 
On the national level, individuals with complete ‘access’ to NCD treatment accounted for 
69.2%, compared to individuals with incomplete access ‘in-access’ to NCDs treatment, who 
accounted for 30.8% (3.3% having partial in-access and 27.5% having complete in-access). 
The prevalence of ‘access’ and ‘in-access’ to treatment among NCD patients is shown in 
table (5). Among the various age groups, those aged from (50- 59) have the highest access (77.4%) 
compared to the lowest age groups whose access to medication averaged 39.5%. In a parallel way, 
NCD patients belonging to urban governorates and/ or the highest wealth quintile (richest) 
achieved above average access to NCD treatments (76%). Females achieved higher access to NCD 
treatments (72%), versus (64%) for males.  
Socio-economic Inequalities in Accessing Treatment of NCDs, EHIS 2015          18 
 Table 4 Background Characteristics of NCD Patients in the working age, Access to NCD Treatment, 
Health Issues Survey, Egypt 2015 
<29 9.3       5.3                           18.2                 
30-39 14.2     12.5                         18.1                 
40-49 30.0     30.2                         29.5                 
50-59 46.6     52.0                         34.3                 
Male 37.9     34.8                         45.4                 
Female 62.1     65.2                         54.6                 
Urban 57.2     60.5                         49.2                 
Rural 42.8     39.5                         50.8                 
Urban governorates^ 22.1     24.9                         15.5                 
Urban lower Egypt 15.8     16.1                         15.0                 
Rural lower Egypt 23.2     23.9                         21.6                 
Urban upper Egypt 15.2     15.2                         15.0                 
Rural upper Egypt 18.6     14.6                         28.1                 
Frontier Governorates 5.1       5.2                           4.8                   
Q1 (poorest) 15.4     12.8                         21.4                 
Q2 15.8     14.2                         19.6                 
Q3 12.2     12.4                         11.7                 
Q4 22.2     23.2                         19.8                 
Q5 (richest) 34.4     37.3                         27.5                 
No education  23.8     24.2                         22.7                 
Some primary 18.6     19.3                         17.1                 
Primary complete/ some secondary 42.9     42.8                         43.0                 
Secondary complete/ higher 14.7     13.6                         17.3                 
Never married 4.4       2.2                           9.7                   
Ever married 95.6     97.8                         90.3                 
Not Employed 53.8     56.0                         48.4                 
Employed 46.2     44.0                         51.6                 
*** p < 0.001
** p < 0.01
* p < 0.05
^ Cairo, Alex, PortSaid, and Suez
Age (years)***
Sex***
Type of place of residence***
Region***
Wealth quintiles***
Education
Marital status***
Employment status**
Individuals with Incomplete 
Access to NCD's Treatment
Individuals with Complete 
Access to NCD's Treatment
n= 1,489                   n= 626
Variable
Total
n=2,115
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  Table 5 Prevalence of ‘Access,’ and ‘In-access’ to NCD Treatment among NCD Patients, 
Health Issues Survey, Egypt 2015 
69.2                30.8                  
<29 39.5                60.5                  
30-39 60.9                39.1                  
40-49 69.8                30.2                  
50-59 77.4                22.6                  
Male 64.6                35.4                  
Female 72.0                28.0                  
Urban 73.4                26.6                  
Rural 65.5                34.5                  
Urban governorates^ 76.0                24.0                  
Urban lower Egypt 71.6                28.4                  
Rural lower Egypt 70.3                29.7                  
Urban upper Egypt 71.6                28.4                  
Rural upper Egypt 55.4                44.6                  
Frontier Governorates 72.8                27.2                  
Q1 (poorest) 57.9                42.1                  
Q2 62.6                37.4                  
Q3 72.6                27.4                  
Q4 71.4                28.6                  
Q5 (richest) 75.6                24.4                  
No education  69.0                31.0                  
Some primary 72.3                27.7                  
Primary complete/ some secondary 69.3               30.7                  
Secondary complete/ higher 65.8                34.2                  
Never married 42.3                57.7                  
Ever married 70.5                29.5                  
Not Employed 72.0                28.0                  
Employed 65.8                34.2                  
*** p < 0.001
^ Cairo, Alex, PortSaid, and Suez
Age (years)***
Sex***
Type of place of residence***
Region***
Wealth quintiles***
Education***
Marital status***
Employment status***
Individuals with Incomplete 
Access to NCD's Treatment
Individuals with Complete 
Access to NCD's Treatment
n= 1,489 n= 626
Variable
National
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n=626
69.2 11.6 72.8 15.6 30.8
<29 39.5 14.7 72.5 12.9 14.7
30-39 60.9 13.8 71.1 15.2 13.8
40-49 69.8 8.7 75.4 15.9 8.7
50-59 77.4 12.5 71.8 15.8 12.5
Male 64.6 12.7 72.9 14.4 12.7
Female 72 11 72.8 16.2 11
Urban 73.4 13.4 72.6 14 13.4
Rural 65.5 9.7 73.1 17.2 9.7
Urban governorates^ 76 18.7 67.8 13.6 18.7
Urban lower Egypt 71.6 9.3 72.2 18.5 9.3
Rural lower Egypt 70.3 8.5 73.5 18 8.5
Urban upper Egypt 71.6 10.3 80.4 9.3 10.3
Rural upper Egypt 55.4 13 72 15 13
Frontier Governorates 72.8 13.5 72.7 13.8 13.5
Q1 (poorest) 57.9 11.8 77 11.2 11.8
Q2 62.6 10 68.5 21.5 10
Q3 72.6 10.5 72.9 16.6 10.5
Q4 71.4 12.4 74.5 13.1 12.4
Q5 (richest) 75.6 12.4 72.5 15.1 12.4
No education  69 11.8 74.5 13.6 11.8
Some primary 72.3 14.2 68.9 16.9 14.2
Primary complete/ some secondary 69.3 10.9 71.9 17.2 10.9
Secondary complete/ higher 65.8 9.8 77.6 12.7 9.8
Never married 42.3 7.1 71.9 21 7.1
Ever married 70.5 11.7 72.8 15.4 11.7
Not Employed 72 11.5 73.3 15.2 11.5
Employed 65.8 11.7 72.2 16.1 11.7
*** p < 0.001
^ Cairo, Alex, PortSaid, and Suez
Type of place of residence***
Region***
Wealth quintiles***
Government Private Both
National
Age (years)***
Sex***
Variable Individuals with Complete Access to NCD's 
Treatment
n=1,489
Education***
Marital status***
Employment status***
Individuals with 
Incomplete Access to 
NCD's Treatment
Total Facility of Recieving Treatment
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The study sample of NCD patients reflected different levels of accessing NCD treatments, 
and, accordingly, different levels of financial burden (out-of-pocket spending). Furthermore, the 
financial burden varied also depending on whether the patient reported receiving care and 
treatment in a governmental healthcare facility, a private facility, or both. 
On average a NCD patient spent 110 EGP monthly (a maximum of 8,000 EGP). Patients 
with complete access to NCD treatment spent, on average, 130 EGP monthly and, surprisingly, 
patients with partial access spent, on average, 154 EGP monthly (P.value < 0.001). In addition, the 
level of monthly spending varied depending on whether the patient received care for his diagnosed 
NCDs in a government health facility (an average of 40 EGP and a maximum of 1,100 EGP); in a 
private health facility (an average of 140 EGP and a maximum of 8,000 EGP); or both (an average 
of 148 EGP and a maximum of 2,000 EGP) (US$1 was equivalent to 7.6 EGP at the time of data 
collection). Table (6) shows the average monthly spending on NCD treatments, in 2015, as 
estimated from the reported incurred costs during the last four weeks before the survey 
 
 
 
 
To assess the likelihood of having a complete access to NCD treatment, and, then, the 
conditional average out of pocket spending, a 2-parts model was estimated. Table (7) shows the 
results of the 2-part model; the coefficients in the logit model were transferred into odds ratios to 
facilitate interpretations.  
Table 6 " The Average Out of Pocket Spending on NCD Treatment (EGP), 
EHIS 2015 
Mean SD Min Max  P. value (ANOVA)
Overall Average 110.29 312.691 0 8000
Partial Access to Treatment 154.29 175.515 0 1100
Complete Access to Treatment 129.57 343.923 0 8000
Receiving Care at a Governmental 
Healthcare Facility 40.11 101.615 0 1100
Receiving Care at a Private Healthcare 
Facility 140.18 382.553 0 8000
Receiving Care at both Governmental and 
Private Healthcare Facility 147.61 158.69 0 2000
< 0.001
< 0.001
* 1 USD =  7.6344 EGP (May 2015)
* SD = Standard Deviation
** A more detailed analysis of Out of Pocket Spending per different subgroups is illustrated in Appendix (2) 
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The model shows that as the age increases, the likelihood of completely accessing NCD 
treatment increases significantly, and this increase is not accompanied by a parallel increase in the 
financial burden of treatment (P-value < 0.001).  Females showed a significant increase in the 
likelihood of completely accessing NCD treatment, while they incurred a significantly less out of 
pocket spending (P-value < 0.001). Among the different regions, Rural Lower Egypt governorates 
and the Frontier governorates have a significantly higher likelihood of completely accessing NCD 
treatment, while having a significantly lower financial burden of treatment (P-value < 0.001).  
NCD patients with no education and those who are employed, have lower likelihood of 
completely accessing treatment, while incurring higher financial burden of the treatment (P-value 
< 0.001). Finally, moving from the poorest to the richest wealth quintiles, the likelihood of 
completely accessing NCD treatment significantly increases (P-value < 0.001), as well as the 
accompanied financial burden of the treatment (P-value < 0.001). 
  
OR P-value Coefficient P-value
30-39 2.299 2.30 - 2.30 < 0.001 65.286 63.79 - 66.78 < 0.001
40-49 3.754 3.75 - 3.76 < 0.001 -14.24 -15.74 - -12.75 < 0.001
50-59 5.707 5.71 - 5.71 < 0.001 34.112 32.62 - 35.61 < 0.001
Female 1.28 1.28 - 1.28 < 0.001 -66.905 -66.95 - -66.86 < 0.001
Urban 0.934 0.98 - 0.98 < 0.001 -18.557 -19.04 - -18.08 < 0.001
Urban lower Egypt 0.85 0.85 - 0.85 < 0.001 -26.227 -26.28 - -26.17 < 0.001
Rural lower Egypt 1.322 1.32 - 1.33 < 0.001 -53.57 -54.05 - -53.09 < 0.001
Urban upper Egypt 0.981 0.98 - 0.98 < 0.001 -23.945 -24.01 - -23.88 < 0.001
Rural upper Egypt 0.865 0.86 - 0.87 < 0.001 8.273 7.79 - 8.75 < 0.001
Frontier Governorates 1.532 1.53 - 1.53 < 0.001 -51.299 -51.57 - -51.03 < 0.001
Q2 1.141 1.14 - 1.14 < 0.001 29.295 29.22 - 29.37 < 0.001
Q3 1.889 1.89 - 1.89 < 0.001 26.111 26.04 - 26.19 < 0.001
Q4 2.132 2.13 - 2.13 < 0.001 15.557 15.47 - 15.64 < 0.001
Q5 (richest) 2.71 2.71 - 2.71 < 0.001 62.634 62.53 - 62.73 < 0.001
No education  0.967 0.97 - 0.97 < 0.001 24.46 24.39 - 24.53 < 0.001
Some primary 1.183 1.18 - 1.18 < 0.001 13.431 13.36 - 13.50 < 0.001
Primary complete 1.316 1.32 - 1.32 < 0.001 20.679 20.62 - 20.74 < 0.001
Ever married 1.285 1.28 - 1.29 < 0.001 31.341 31.15 - 31.53 < 0.001
Employed 0.709 0.71 - 0.71 < 0.001 0.83 0.78 - 0.88 < 0.001
OR = odds ration; CI = confidence interval
Marital status*
Employment
Probability of Having Complete 
Access to NCD Treatment Conditional Out-of-Pocket Expenditure
Age (years)
Sex
Type of place of residence
Region
Wealth quintiles*
Education*
95% CI 95% CI
Table 7 Two-Part Model representing the likelihood of having a full access to NCDs’ treatment and the 
incurred level of monthly out of pocket spending by NCD Patients, EHIS 2015 
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Inequalities in Complete Access to NCD Treatments 
Inequality is a complex concept that can be measured and conveyed using a variety of 
statistical techniques. With the goal to provide a quantitative estimate of inequality in accessing 
treatment among Egyptian NCD patients, a variety of measures are calculated to fully explore the 
situation.  
For inequality measurements, the focus is on those who does not have a complete access 
to NCD treatment. Therefore, the access to treatment indicator used is the prevalence of ‘in-access’ 
to treatment among NCD patients. i.e. the percentage of NCD patients with incomplete access (in-
access) to NCD treatments. As a starting point, the percentage of the ‘in-access’ to treatment 
indicator, across the different subgroups (strata), is shown in table (5). 
At the most basic level, simple (gap) measures of inequality usually portray a simple, 
intuitive and easily understood description of inequality. Pairwise comparison between 
dichotomous stratifiers was used to estimate the absolute and relative inequality across; youngest 
versus oldest age groups, sex, type of place of residence, highly-educated versus non-educated, 
poorest versus richest, ever-married versus never married, and employed versus not employed. 
The results as displayed in table (8), and, visually, illustrated in Appendix (3) 
 
The simple measures reflected 
the presence of inequalities in accessing 
NCD treatment, mostly evident in age 
(37.9% absolute gap and 2.7 relative gap) 
and sex (36.6% absolute gap and 2.3 
relative gap) subgroups. The wealth-
based inequality is, also, evident (17.7% 
absolute gap and 1.7 relative gap), while, 
the least inequality can be seen among 
education based subgroups (3.2% 
absolute gap and 1.3 relative gap). 
 
Table 8 Incomplete Access to NCD Treatment, Simple (Gap) 
Measures of Inequality, EHIS 2015 
Absolute Gap 
(%)
Relative Gap 
Youngest (<29) 60.5
Eldest (>50) 22.60
Males 64.6
Females 28.00
Rural 34.5
Urban 26.60
Educated (higher-
education) 34.2
Non-Educated 31.00
Poorest 42.1
Richest 24.40
Never Married 57.7
Ever Married 29.50
Employed 34.2
Not Employed 28.00
Simple Measures of 
Inequality
1 Age 37.90 2.68
7 Employment 6.20 1.22
4 Education 3.20 1.10
5 Wealth 17.70 1.73
6 Marital Status 28.20 1.96
2 Sex 36.60 2.31
3 Residence 7.90 1.30
Stratifier Social Groups
Percent of Patients with 
Incomplete Access to NCD 
treatment
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Since complex (gradient) measures of inequality, significantly, contribute to the inequality 
picture by considering all subgroups and taking into consideration the relative size of each 
subgroup. The analysis considered, first, complex (gradient) measures relying on the 
prevalence; (a) the Absolute Mean Difference (MD) & the Weighted Absolute Mean Difference 
(wMD), the Standard Deviation from the mean (SD) and the Weighted Standard Deviation from 
the mean (wSD), (b) Population Attributable Risk (PAR and PAR%), and, finally, (c) the Slope 
Index of Inequality (SII).  
Initially, the absolute (and relative) mean differences, as well as, the absolute (and relative) 
standard deviations from the mean were calculated (Table 9). These measures evaluate, across the 
different stratifiers, how different is each subgroup, on average, from the population average, and 
from the other subgroup(s). (WHO, 2013)  
The weighted measures are, generally, more appropriate and intuitive representations of 
inequality since they consider the size of each subgroup. Hence, it is evident that there are different 
variation levels among the different stratifiers’-based subgroups, with the highest variations 
(inequalities) can be seen among the age, region, and wealth-based strata (subgroups).  
 
Conceptualized on the premise that inequality could be eliminated by improving the level 
of a health indicator in a population to match the best-performing subgroup, the population 
attributable risk (PAR and PAR%) were calculated. Figure (3) illustrates the population 
attributable risk, calculated by comparing the percentage of incomplete access to NCD treatment 
at the national (population) level, with the best performing subgroup per each used stratifier. Age, 
wealth, and region based inequalities have the highest PAR percentages: (26.6%), (22.1%), and 
(20.8%), respectively.   
Table 9 Mean Deviation, Standard Deviation, and, their corresponding Relative Measures, 
EHIS 2015 
∗ The details of the Calculation are explained in Appendix (4). 
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As a single summarizing measure of inequality that can represent the difference between 
the lowest (worst-off) and the highest (better-off), while considering all other subgroups and their 
proportional population size, the slope index of inequality (SII) was calculated for two ordinal 
stratifiers; wealth and education. The wealth-based SII is (-22.36), while the education-based SII 
is (-5.00337). (Appendix (6) illustrates the slope index of inequality calculations in EHIS, 2015).   
Finally, the analysis considered, the second group of complex (gradient) measures, those 
relying on the outcome distribution across all subgroups of the population as compared to the 
expected distribution. These measures are conceptualized with the premise that under complete 
equality, everyone’s share of health (Sjh) should be equal to his/her population share (Sjp). 
Distribution-based complex measures of inequality include; (a) Index of Dissimilarity (ID) and 
Index of Dissimilarity Percent (ID%), (b) Theil Index (T) (for nominal or non-ordered stratifiers), 
and (c) Concentration Index (CI) (for ordinal or ordered stratifiers). 
Table (10) illustrates both the absolute Index of Dissimilarity (ID) and the relative Index 
of Dissimilarity (ID%). Three main stratifiers were found to have the highest inequalities; age, 
wealth, and regions; with indices of dissimilarity percentages of 26%, 19%, and 15% respectively. 
As a measurement of relative inequality between non-ordered population subgroups, Theil 
Index (T) was calculated for the sex, type of place of residence, region, marital status, and 
0 5 10 15 20 25 30 35
Age (years)
Sex
Type of place of residence
Region
Wealth quintiles
Education
Marital status
Work
Individuals with Incomplete Access to NCD Treatment (%)
Access to NCDs Treatment Inequalities, Population Attributable Risk, EHIS, 
2015
Individuals with inaccess to NCD Treatment) Population Attributable Risk (within country inequality
PAR%
(26.6%)
(9.1%)
(13.6%)
(22.1%)
(20.8%)
(10.1%)
(4.2%)
(9.1%)
Figure 3 Access to NCDs Treatment Inequalities, Population Attributable 
Risk, EHIS, 2015 
*PAR and PAR% Calculations are illustrated in Appendix (5) 
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employment based stratifiers, as seen in table (11). The regions-based stratification reflects the 
highest inequalities (Theil index, multiplied by 1,000 equals to 19.8). 
 
 
 
For subgroups with natural ordering, education and wealth based strata, the Concentration 
Index (CI) was calculated. Concentration Index is one of the most commonly used measures of 
health inequality. It indicates “the extent to which a health indicator is concentrated among 
the disadvantaged or the advantaged” [9]. The wealth-based concentration index is (-0.12, P-
value < 0.001), while the Education-based concentration index is (-0.01, P-value > 0.05). Figure 
(4) shows the concentration curves for both wealth and education based inequalities in incomplete 
access to NCD treatment.  
 
 
 
 
 
 
 
 
*ID and ID% Calculations are illustrated in Appendix (7) 
ID 
(Absolute)
ID %
(Relative)
84,225,482     26%
36,594,574     11%
42,177,826     13%
50,074,842     15%
60,994,080     19%
12,064,029     4%
26,062,880     8%
32,874,908     10%
Stratifier 
Age (years)
Sex
Type of place of residence
Region
Wealth quintiles
Education
Marital status
Employment
Table 10 Index of Dissimilarity (ID & ID%), EHIS 2015 
5.039           
6.686           
19.812         
13.903         
3.731           
Theil index,  
multiplied by 1000
Employment
Stratifier 
Sex
Type of place of residence
Region
Marital status
**Theil Index Calculations are illustrated in Appendix (8) 
Table 11 Theil Index, EHIS 2015 
0
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Relative Wealth-based Inequality in Incomplete 
Access to NCD Treatment in Egypt, represented 
using Concentration Curves, EHIS 2015 
Cumulative	Fraction	of	NCD	Patient	with	Incomplete	access	to	Treatment Equality	Line
0
0.2
0.4
0.6
0.8
1
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0 0.2 0.4 0.6 0.8 1 1.2
Relative Education-based Inequality in Incomplete 
Access to NCD Treatment in Egypt, represented 
using Concentration Curves, EHIS 2015 
Cumulative	Fraction	of	NCD	Patient	with	Incomplete	access	to	Treatment Equality	Line
Figure 4 The  concentration curves for both wealth and education based inequality in 
incomplete access to NCD treatment, EHIS 2015 
 
**The Concentration Index (CI) and Concentration Curves Calculations are illustrated in Appendix (9) 
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The concentration index of a health variable is additively decomposable into the 
concentration indices of its determinants [33, 34]. Therefore, to estimate how determinants 
proportionally contribute to inequality in the ‘in-access to NCD treatment’ variable, the 
concentrations index was decomposed into its main socio-economic determinants, using the 
appropriate model(s) of multiple regression analysis. Appendix (10) explains the details of the CI 
decomposition analysis.  
Figure (5) illustrates the results of the decomposition analysis, where the largest 
contribution to inequality in completely accessing NCD treatment were attributable to household 
economic status or wealth quintiles (98%). Furthermore, education (16%), age (13%), and 
residency in rural/urban areas (11%) show considerable contributions to the measured inequality.  
 
  
Figure 5 Decomposing Socio-economic Inequality in "In-accessing NCD Treatment," EHIS, 2015 
98%
16%
13%
11%
0.4%
-3%
-9%
-27%
-40% -20% 0% 20% 40% 60% 80% 100% 120%
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VI. Discussion 
Access to NCD Treatment and Financial Burden 
Access to essential medicines is an important aspect of development. It was part of the 
Alma Ata Declaration of 1978, and is one of the Sustainable Development Goals 2030 [2, 15]. 
However, the suboptimal availability of NCD medicines in developing and low income countries 
[25-29] and the unacceptably low access to NCDs medicines are calling for the further use of 
indicators and targets for access to NCD medicines in order to monitor progress. Only with these 
approaches can a difference be made to the lives of hundreds of millions of current and future 
patients with NCDs [15].  
In Egypt, the healthcare system is pluralistic with multiple sources of financing and 
multiple service providers; the Ministry of Health & Population (MOHP) and the Health Insurance 
Organization (HIO); as well as other Ministries and public sector entities such as the Curative Care 
Organization, Teaching Hospitals and Institutes, and non-governmental organizations (NGOs) [4, 
41]. Furthermore, while a universal health insurance is a challenging to fully-realize constitutional 
right, there are different health insurance schemes; the employment-based health insurance, which 
is the dominant scheme targeting the productive population; and other schemes including: private 
health insurances, insurance through the MOHP, syndicates, and schools [36].  
The analysis results showed that on the national level, individuals with complete ‘access’ 
to NCD treatment accounted for 69.2%, compared to individuals with incomplete access ‘in-
access’ to NCDs treatment, who accounted for 30.8% (3.3% having partial in-access and 27.5% 
having complete in-access). This percentage is well above the 2012 WHO voluntary target for 
drug treatment, which is 50% of eligible people receive drug therapy [15, 38].  However, given 
the Egyptian context of having the largest pharmaceutical industry base in the Arab and MENA 
region [48], the pharmaceutical market is a well-developed market with many cost-effective 
generic medications, and multiple governmental initiatives to improve the public sector 
procurement and availability of medications [39, 40], such overall ‘in-access’ percentage is 
relatively high, and calls for more efforts.  
Overall, NCD patients reported accessing care and treatment for their diagnosed diseases 
mainly at private healthcare facilities (72.8%), compared to governmental healthcare facilities 
(11.6%), or both governmental and private facilities (15.6%). Such overwhelmingly prevalence of 
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seeking care and treatment at private sector facilities over governmental facilities should be a major 
concern, as concluded previously “the majority of Egyptians have access to [almost] free care 
through a government facility within five kilometers of their place of residence, and still the 
majority of outpatient visits took place in the private sector” [41]. Such tremendous preference of 
private healthcare facilities, irrespectively of income, place of residence, gender, age, and 
educational level, can be explained by accessibility and quality of service, individuals’ perception 
of quality of care, good treatment, prior experience, and specialized staff [41]. 
Among the various age groups, those aged from (50- 59) have the highest access (77.4%) 
compared to the lowest age groups whose access to NCD medications averaged, (39.5%). This 
result was evident even after controlling for other socioeconomic variables, where the likelihood 
of completely accessing NCD treatment in higher age groups is significantly higher than lower age 
groups. This finding is reinforced with previous results reporting that, in Egypt, as the age 
increases, health service utilization increases significantly [36].  
The improved age–based access to NCD treatment can be explained in terms of having 
better awareness about the diagnosis, need for treatment, and the available channels of healthcare 
service utilizations. This improved access to treatment is not accompanied by a parallel increase 
in the financial burden of treatment “out of pocket spending,” nor higher access and utilization of 
healthcare services in governmental healthcare facilities, therefore, we can argue that higher age-
group NCD patients have better access to NCD treatment through insurance based services, mainly 
private insurance schemes.  
Female NCD patients, enjoyed a higher access to complete NCD treatment (72%), 
compared to male NCD patients (64.6%). Even after controlling for other socio-economic 
variables, females showed a significant increase in the likelihood of completely accessing NCD 
treatment. This higher access to treatment was accompanied by a significantly less out of pocket 
spending; females, on average, spend 67 EGP monthly less than males. This can be interpreted as 
part of the overall health service utilization, where females, compared to males, were found to 
have a significantly higher likelihood of health service utilization, with a lower conditional 
expenditure on health [36]. 
Probably such higher access to treatment and lower out of pocket spending can be 
explained in the light of having different programs and initiatives targeting women and maternal 
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health in general, mostly by the MOHP and a number of NGOs. A previous study on “the 
Utilization of Outpatient Care in Egypt” also reported that females have a higher annual rate of 
outpatient health services utilization compared to males; among the different providers analyzed, 
the higher female-based health service utilization was realized using the MOHP and private 
providers [41]. Our results, supported this finding, by demonstrating that females have accessed 
NCD care and treatment in “both governmental and private healthcare facilities” (16.2%), 
significantly higher than males (14.4%). 
Urban governorates (Cairo, Alexandria, Port Said, and Suez) signaled the highest NCD 
treatment access; 76% of NCD patients in these governorates have complete access to NCD 
treatment. Controlling for other variables, the analysis revealed that, compared to urban 
governorates, urban lower and upper Egypt governorates, and rural upper Egypt governorates have 
less likelihood of completely accessing NCD treatment. In contrary, rural lower Egypt and the 
frontier governorates have higher likelihood of completely accessing NCD treatment, with less 
incurred financial burden; on average NCD patients in both regions spend around 50 EGP monthly 
less than NCD patients in other regions. Such variability reflects the need for more institutional 
reform on the level of the different governorates. 
Wealth has always been a main determinant to access to healthcare and treatment [42]. Our 
results confirmed this widely believed pattern, where complete access to NCD treatment was 
increased significantly as we move across the wealth quintiles; (57.9%) among the poorest, and 
(75.6%) among the richest wealth quintile. Henceforth, controlling for other variables, the 
likelihood of completely accessing NCD treatment significantly and progressively increased 
among NCD patients of the second, third, forth, and fifth, compared to the first, wealth quintiles.  
This increase in the likelihood of complete access to NCD treatment was also accompanied 
by an increase in the out of pocket spending but not in a parallel way. Compared to NCD patients 
belonging to the first wealth quintile (poorest), the results showed that NCD patients belonging to 
the second wealth quintile (poorer) spend, on average, 29 EGP more monthly; and NCD patients 
belonging to the fifth wealth quintile (richest) spend, on average, 63 EGP more. However, looking 
at the third (middle) and forth (richer) wealth quintiles, the results reflected that they spend, on 
average, 26 EGP and 15 EGP only more than those of the first wealth quintile.  
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This can be explained in the light of an earlier study about the public healthcare subsidies 
in Egypt, where public subsidies to healthcare services in Egypt have been found to be pro-rich, 
meaning that subsidies tend to benefit wealthier groups more than the poorer groups [43]. 
Therefore, while it is widely perceived that the poor benefit the most from health subsidies, and 
hence, will incur lower financial burden for treatment, our findings contribute to refute this 
hypothesis in the case of Egypt and among NCD patients where the richer NCD patients would 
spend, on average, less out of pocket than the poorer patients. Additionally, the richer and richest 
NCD patients have the highest prevalence of accessing care and treatment in a governmental health 
facility (12.4%); compared to (10.5%), (10%), and (11.8%) in the middle, poorer, and poorest 
groups respectively. And, the poorest NCD patients have the highest prevalence of accessing care 
and treatment in a private health facility (77%); compared to (68%), (73%), (74%), and (72%) in 
the poorer, middle, richer and richest groups respectively. 
The ever married NCD patients were found to have higher likelihood of completely 
accessing NCD treatment, with a higher out of pocket spending (around 30 EGP on average) than 
the never married NCD patients. Our analysis results conform with prior results on the impact of 
the different socio-economic factors on the pattern of seeking care for illness, where it was reported 
that married individuals are significantly more likely to seek care [41].  
However, our results contradict prior findings when it comes to education. Earlier it was 
reported that more educated individuals are significantly more likely to seek care [41]. 
Controversially, the results of our analysis raised the concern that among different education-based 
social groups, NCD patients with secondary or higher educational level were found to have the 
least access to complete NCD treatment (65.8%). Controlling for other variables, NCD patients 
with some primary education and those with complete primary and some secondary were found to 
have higher likelihood of completely accessing NCD treatments than patients with secondary or 
higher education.  
Finally, while the dominant health insurance system in Egypt targeting the productive 
population is the employment-based scheme [36], our results showed that this scheme is not well 
reflected in terms of complete accessibility to NCD treatment and financial burden. Complete 
access to NCD treatment was higher among unemployed NCD patients (72%) compared to 
employed ones (65.8%). Therefore, controlling for other variables, employed NCD patient tended 
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to have less likelihood to completely access NCD treatment than unemployed patients, confirming 
the earlier results that “current employment-based [insurance] scheme was not effective in 
increasing health service utilization, but succeeded in reducing out-of-pocket expenditure on 
health” [36]. Yet, our analysis results find out that employed NCD patients were not even better 
off in terms of financial burden or out of pocket spending than unemployed ones.  
 
Inequalities in Accessing NCD Treatment 
According to the WHO (2013), “health inequalities continue to persist around the world in 
general, and in low- and middle-income countries in particular, such inequalities in health become 
strikingly apparent when looking at social determinants” [9]. Additionally, “a necessary 
prerequisite to creating an equity-oriented health sector is to systematically identify where 
inequalities exist, and then monitor how [these] inequalities change over time” [Ibid]. Therefore, 
a main focus of this study is to assess the extent to which the different socio-economic determinants 
impact equitable access to NCDs treatment in Egypt, represented in; high blood pressure, diabetes 
and cardiovascular disease (stroke and heart attack). 
Inequality is a complex concept that can be measured and conveyed using a variety of 
absolute and relative measures; simple (gap) and complex (gradient) measures; ordered groups and 
non-ordered groups measures; and prevalence-based and distribution-based measures. With the 
goal to provide a quantitative estimate of inequality in accessing treatment among Egyptian NCD 
patients, and with a focus on those who does not have a complete access to NCD treatment, a 
variety of measures were calculated to fully explore the situation and provide a fuller picture of 
the existing inequalities. The main highlighted inequality measures are summarized in appendix 
(11). 
At its most basic level, simple (gap) measures highlighted the presence of inequalities in 
accessing NCD treatment, mostly evident in age (37.9% absolute gap and 2.7 relative gap) and sex 
(36.6% absolute gap and 2.3 relative gap) subgroups. The wealth-based inequality is, also, evident 
(17.7% absolute gap and 1.7 relative gap), while, the least inequality can be seen among education 
based subgroups (3.2% absolute gap and 1.3 relative gap). 
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In order to include the different subgroups per each stratifier, while taking the relative size 
of each subgroup into consideration as well, complex measures of inequality are always useful 
policy oriented tools.  
The first insightful measures of inequality among different subgroups; ordered and non-
ordered, are the absolute and relative weighted mean differences, as well as, the absolute and 
relative weighted standard deviations from the mean. These measures evaluate, across the different 
stratifiers, how different is each subgroup, on average, from the population average, and from the 
other subgroup(s) [9]. The highest variations (inequalities) were found to be among the age-based 
strata; (7.92) weighted mean deviation from mean and (0.26) weighted mean deviation to mean 
ratio. Likewise, wealth-based strata reflected high variations; (5.75) weighted mean deviation from 
mean and (0.19) weighted mean deviation to mean ratio. Region-based strata highlighted one of 
the highest variations as well; (5.02) weighted mean deviation from mean and (0.16) weighted 
mean deviation to mean ratio, and the highest weighted standard deviation to mean ratio (0.46). 
The second intuitive and rational complex measure is the population attributable risk (PAR 
and PAR%), which is “based on the premise that inequality could be eliminated by improving the 
level of a health indicator [access to NCD treatment] in a population to match the best-performing 
subgroup [9]. Therefore, it reflects “the possible improvements if all subgroups had the same rate 
as a reference subgroup, which, basically, has the best outcome or, when the subgroups are ordered, 
the highest social position (richest or most educated)” [Ibid]. Our calculated PAR percent 
highlighted that the national inequality could be reduced by almost one quarter if the whole 
population has the same access to NCD treatment as either individuals within (50-95) age group, 
or those belonging to the richest quintile, or even, those living in Urban governorates (Cairo, Alex, 
Port Said, and Suez). 
The analysis, then, shifted to another group of measures, those based on the distribution of 
the health indicator and, therefore, conceptualized with the premise that under complete equality, 
everyone’s share of health (Sjh) should be equal to his/her population share (Sjp). The third 
inequality measure is the index of dissimilarity (ID), which “expresses the extent to which the 
distribution of the health event studied [access to NCD treatment] in the population approximates 
the situation in which everyone has the same socioeconomic level [44]. Therefore, ID assesses the 
differences of resource allocation in different levels or groups and calculate the degree of variance 
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[Ibid]. The analysis showed that three main stratifiers have the highest inequalities in this regard; 
age, wealth, and regions; with indices of dissimilarity percentages of 26%, 19%, and 15% 
respectively. Likewise, the Theil index (T) measures equity of the allocation of health resources 
between different regions or units [44]. Hence, it is a very helpful “measurement of relative 
inequality between subgroups in cases where there is no natural ordering among population 
subgroups” [9]. Among different stratifiers, region-based stratification reflected high inequality 
(Theil index, multiplied by 1,000 equals to 19.8). 
Finally, and as recommended by the WHO, “the two most common complex measures to 
summarize health inequality in a series of subgroups with a natural ordering are the slope index of 
inequality [SII] shows absolute inequality, taking into account the mean value of the health 
indicator in each subgroup; and the concentration index [CI] is a measure of relative inequality, 
expressing the disproportionate distribution of a health indicator among subgroups. A common 
strength of both of these measures is that their calculation involves weighting by the size of the 
population, enabling them to yield a single number that describes inequality among all subgroups, 
taking into account the population size” [9].  
Our analysis found a significant level of wealth-based inequality; the SII is (-22.36) and 
the CI is (-0.12), compared to an insignificant education-based inequality; the SII is (-5) and the 
CI is (-0.01). This can be explained that wealth is a main determinant when it comes to completely 
accessing NCD treatment, and the main ‘in-access’ problems are caused by affordability 
challenges, not awareness or knowledge problems which are usually expected to be better among 
individuals with higher educational levels.  
Overall the wealth-based inequality (CI = -0.12) can be classified as a moderate level 
inequality. Hence, the challenges of completely accessing NCD treatments are moderately 
concentrated among the disadvantaged subgroups. 
In order to estimate how the different socio-economic determinants proportionally 
contribute to this “in-access to NCD treatment” inequality, the concentration index was 
decomposed into its determinants and the results confirmed the main role played by the household 
economic status or wealth index where almost (98%) of the detected inequality was caused by 
inequalities in wealth. Education, age, and type of place of residence inequalities appeared to have 
smaller but yet considerable contributions; (16%), (13%), and (11%) respectively.  
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VII. Conclusion 
The overall percentage of NCD patients, who lack a complete access to the essential NCD 
treatment in Egypt, averages to 30.8%. A relatively high number, that calls for more efforts to 
ensure better access to treatment. The majority of NCD patients with complete access to treatment 
seek treatment for their conditions at private health care facilities (72%). Hence, they incur higher 
financial burden; the average out-of-pocket spending on treatment in a private health care facility 
is 3.5 times more than the average out-of-pocket spending on treatment in a governmental 
healthcare facility.  
NCD treatment is an essential treatment that should be accessible for all patients 
irrespective of their age, sex, place of residence, economic status, etc. However, significant 
inequalities in accessing NCD treatment were detected among the different social groups. The 
main socioeconomic stratifiers for the detected inequality includes: wealth, age, sex and region. 
Complete access to NCD treatment is skewed against the poor, young-aged, males and those living 
outside Urban Governorates. Inequalities in the different socioeconomic factors impacted the 
inequality in accessing treatment with varying degrees; the main determinant is wealth, responsible 
for over 90% of the detected inequality; followed by education, age, and type of place of residence.  
This study contributes to the empirical evidence that socio-economic inequalities are 
unfair, as they put certain groups of people at a disadvantage, not only economically, socially, and 
politically but also in terms of their health.  
Generally, policymakers should work on improving the overall population access to NCD 
treatment through improving medications availability and affordability at both private and 
governmental healthcare facilities. The recent approval of the Universal Health Coverage Law is 
considered to be a big step towards ‘Health for All’ [45]. However, while the system will be 
gradually applied between 2018 and 2032, policy makers need to reduce or eliminate the detected 
inequalities by targeting the worst-off groups through special access programs. Moreover, 
institutional reforms targeting improved medication availability and efficient supply chain 
procedures at the level of the directorates of health in each governorate can address the regional 
inequalities to a great extent. 
Finally, the WHO has long endorsed the importance of health inequality data as a 
foundation for incorporating equity into evidence-based health planning, and also assessing 
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whether current health initiatives promote equity [32]. Therefore, this study should provide a basis 
for recasting government pharmaceutical policy toward providing better and affordable access to 
NCD treatment with the ultimate objective of ensuring equitable access for all members of society, 
especially the most disadvantaged. The results and inequality data generated from this research 
should provide a foundation for incorporating equity into evidence-based health planning, and also 
assessing whether current health initiatives promote equity in accessing treatment. 
 
VIII. Study Limitations and Recommendations for Further 
Research 
The results obtained from this study will be useful in assessing the inequity in accessing 
treatment among the majority of NCD patients. However, the results should be interpreted with 
caution as they do not refer to actual prevalence of NCDs. Many individuals with NCDs, especially 
those who might be diabetics, can be unaware that they have these conditions. Therefore, the self-
reported prevalence and access to treatments recognized in the 2015 EHIS might be 
underestimated than their extent in the population. Additionally, such underestimation is expected 
to be higher in low socio-economic groups, where socially disadvantaged individuals with less 
education and living in places with poor medical and health facilities fail to perceive and report 
the presence of illness and thus fail to seek healthcare.  
It will be insightful if the next wave of the Egyptian Demographic and Health Survey 
included data on the same variables. Hence, a follow up analysis can be performed to assess the 
progress of the situation in Egypt in regards to pharmaceutical availability and accessibility.  
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XI. Appendices 
 
Appendix (1): The Variables used in the Analysis (EHIS, 2015 Dataset) 
Name Label Type Original DHS_Variable Description (If Any)
1 WEIGHT Weight Weight
2 age Age A110
<= 29 1 IF  (A110 <= 29) age_c=1
30-39 2 IF  (30 >= A110 <= 39 ) age_c=2
40-49 3 IF  (40 >= A110 <= 49 ) age_c=3
50-59 4 IF  (50 >=  A110 <= 59 ) age_c=4
Male 1
Female 2
Married 1
Widowed 2
Divorced 3
Separated 4
Signed Contract 5
Never Married 6
Ever Married 1 IF  (A111 <= 5) marital_status=1
Never Married 0 IF  (A111 = 6) marital_status=0
Urban 1
Rural 2
Cairo 1
Alexandria 2
Port Said 3
Suez 4
Damietta 11
Dakahlia 12
Sharkia 13
Kalyubia 14
Kafr El-Sheikh 15
Gharbia 16
Menoufia 17
Behera 18
Ismailia 19
Giza 21
Beni Suef 22
Fayoum 23
Menya 24
Assuit 25
Souhage 26
Qena 27
Aswan 28
Luxor 29
Red Sea 31
New Valley 32
Matroh 33
North Sinai 34
South Sinai 35
Urban Governorate 1 IF  (AGOVERN <= 10) region=1
Lower Urban Governorate 2 IF  (AGOVERN <= 20 & AGOVERN >= 11 & ATYPE = 1) region=2
Lower Rural Governorate 3 IF  (AGOVERN <= 20 & AGOVERN >= 11 & ATYPE = 2) region=3
Upper Urban Governorate 4 IF  (AGOVERN <= 30 & AGOVERN >= 21 & ATYPE = 1) region=4
Upper Rural Governorate 5 IF (AGOVERN <= 30 & AGOVERN >= 21 & ATYPE = 2) region=5
Frontier Governorate 6 IF  (AGOVERN >= 31) region=6
10 education Education in single years V133
No Education 0
Primary 1
Secondary 2
Higher 3
12 wealth_scale Wealth index factor (5 decimals) HWLTHF
Poorest 1
Poorer 2
Middle 3
Richer 4
Richest 5
Employed 1 IF  (A125=value)Employment=1
Not Employed 0 IF  (A125=sysmiss)Employment=0
14 employment Employment Status Nominal (Dummy) A125
13 wealth Wealth Index Quintile Ordinal HWLTHI
Scale
Scale
8 governorate Governorates Nominal AGOVERN
9 region_6 Regions Nominal AGOVERN & ATYPE
Type of Place of Residence Nominal ATYPE
6 marital_status Marital Status Nominal A111 (recoded)
11 education_c Education Ordinal V106
Variables Used in the Analysis  
Values
Sample weight for women/men/children  (6 decimals)
Scale
3 age_c Age Ordinal A110
4 sex Sex Nominal AGEND
5 marital_status_d Marital Status Detailed Nominal A111
7 residence_type
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Name Label Type Original DHS_Variable Description (If Any)
Variables Used in the Analysis  
Values
Yes 1 IF  (A1014=4,5,6), HTN=1 IF  (A1014 =1,2,3 & A404 = 1) HTN=1
Others (No, Don’t Know, not 
sure, missing) 0 IF (otherwiese) HTN=0 
Yes 1 IF  (A408= 1) DM=1
All Others (No, Don’t Know, 
not sure, missing) 0 IF  (A408⍯ 1) DM=0
Yes 1 IF  (A413= 1) MI=1
All Others (No, Don’t Know, 
not sure, missing) 0 IF  (A413⍯ 1) MI=0
Yes 1 IF  (A418= 1) Stk=1
All Others (No, Don’t Know, 
not sure, missing) 0 IF  (A418⍯ 1) Stk=0
19 NCD_Number Number of NCDs NCD_Number = HTN+DM+MI+Stk
NCD 1 IF (NCD_Number >= 1), NCD = 1
Non NCD 0 IF (NCD_Number = 0), NCD = 0
Yes 1 IF  (A404 =1) HTN_tt=1 
No (including missing) 0 IF  (A404⍯ 1) HTN_tt=0
Yes 1 IF  (A410 =1) DM_tt=1 
No (including missing) 0 IF  (A410⍯ 1) DM_tt=0
Yes 1 IF  (A415 =1) MI_tt=1 
No (including missing) 0 IF  (A415⍯ 1) MI_tt=0
Yes 1 IF  (A420 =1) Stk_tt=1 
No (including missing) 0 IF  (A420⍯ 1) Stk_tt=0
25 NCD_tt_Number Number of Treated NCDs NCD_tt_Number = HTN_tt + DM_tt + MI_tt + Stk_tt
26 OOP_spending_NCDs Out of Pocket Spending on NCDs
A428 (In total, how much have you 
spent for care/treatment for the 
(condition's) in the past four weeks?)
Government 1 IF  (A427=1) facility_NCD_tt =1
Private 2 IF  (A427=2) facility_NCD_tt =2
Both Government and Private 3 IF  (A427=3) facility_NCD_tt =3
IF  (A427=4) facility_NCD_tt =systemmissing
28 access_NCD_tt Access to NCD Treatment
NCD_Treatment_Access =(NCD_tt_Number 
/ NCD_Number)*100
Complete Inaccess to NCD 
Treatment
0
IF  (NCD_tt_access =0), 
access_NCD_tt_3C=0 
Partial Access to NCD 
Treatment
1
IF  (NCD_tt_access >0 & 
NCD_tt_access<100) a,ccess_NCD_tt_3C=1
Complete Access to NCD 
Treatment
2
IF  (NCD_tt_access =100) 
access_NCD_tt_3C=2
No 0
IF  (NCD_tt_access <100) 
NCD_tt_access_dummy=0 
Yes 1
IF  (NCD_tt_access =100) 
NCD_tt_access_dummy=1
inaccess 1
IF  (NCD_tt_access <100) 
NCD_tt_access_dummy=0 
access 0
IF  (NCD_tt_access =100) 
NCD_tt_access_dummy=1
PRE_1
Predicted probability of 
Access to treatment
Yes 1 IF (PRE_1>0.5), Pre_Access_NCD_tt = 1
No 0 IF (PRE_1=<0.5), Pre_Access_NCD_tt = 0
34 PRE_inaccess_log
Predicted probability of 
Inaccess to NCD 
Treatment (logistic)
PRE_inaccess_lin
Predicted probability of 
Inaccess to NCD 
Treatment (linear)
A new Dataset was created by filtering out patients without any NCDs (i.e. NCD_Number=0), the new dataset named "DHS_2015_NCDpatients," and it contains only respondent with one or 
more NCD (2,115 case) 
Scale
Scale
Scale
Scale
30 access_NCD_tt_D
Access to NCD 
Treatment_Dummy
Nominal 
(Dummy)
27 facility_NCD_tt Facility of Receiving NCD Treatment Nominal
A427 (Currently receiving care for 
conditions in 428 in a government 
health facility or in a private health 
facility)
NCD Patients DataSet "2_EHIS_2015_Individual_NCD.sav"
24 Stk_tt Stroke Treatment Nominal (Dummy) A420 (receiving medications for Strock)
20 NCD NCD
31 inaccess_NCD_tt_D
Inaccess to NCD 
Treatment_Dummy
Nominal 
(Dummy)
29 access_NCD_tt_3C
Access to NCD 
Treatment_3 Categories
Nominal
22 DM_tt Diabetes Treatment Nominal (Dummy)
A410 (receiving medications for 
Diabetes)
23 MI_tt
Heart Attack or 
Myocardial Infarction 
Treatment
Nominal 
(Dummy)
A415 (receiving medications for Heart 
Attack or Myocardial Infarction)
Nominal 
(Dummy)
21 HTN_tt Hypertension Treament Nominal (Dummy) A404 (receiving medications for HTN)
17 MI
Heart Attack & 
Myocardial 
Infarction_Diagnosed
Nominal 
(Dummy) A413
18 Stk Stroke_Diagnosed Nominal (Dummy) A418
15 HTN Hypertension Nominal (Dummy)
A1014 
(Measurments Categories of HTN) &  
A404 (receiving medications for HTN)
16 DM Diabetes_Dignosed Nominal (Dummy) A408
32
*for the second part of the 2-parts regression model
Scale
Nominal 
(Dummy)Pre_Access_NCD_tt
Predicted Access to 
NCD Treatment
Scale
Scale
* for the calculation of the CI
*for the second part of the 2-parts regression model
33
35
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Age (Age) 
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Age_c (Age) 
 
 
 
 
 
 
Sex 
 
 
 
 
 
Marital Status Detailed 
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Marital Status  
 
 
 
 
 
 
 
Type of Place of Residence 
 
 
 
 
 
 
Governorates 
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Regions (6 regions) 
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Education 
 
 
 
 
Education (Single Years) 
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Wealth (Wealth Index Quintile) 
 
 
 
 
 
Employment 
 
 
 
 
 
 
 
  
N.B: 
Ø For the coding of the NCDs variables {HTN, DM, MI & Stk}; the final 
variable will be coded into dummy variable having the value of either (1) for 
those who have the specific NCD & (0) for all other cases including the 
system missing in order to avoid the unnecessary loss of cases in the 
calculation. 
Ø The same, will be done with coding the NCDs_treatment variables { HTN_tt, 
DM_tt, MI_tt & Stk_tt}; the final variable will be coded into dummy variable 
having the value of either (1) for those who receive treatment for the specific 
NCD & (0) for all other cases including the system missing in order to avoid 
the unnecessary loss of cases in the calculation. 
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Hypertension 
 
A1014 (The correct code for blood pressure) “Hypertension based on Measurement” 
 
Based on the measurement categories (A1014) where (1=optimal, 2=Normal, 3=High Normal, 
4=Mildly Elevated (stage1), 5=Moderately elevated (stage 2), 6= Severely elevated (stage 3)) 
 
 
 
 
 
 
 
 
 
 
A401 (Ever been told by a doctor or other health professional that you had hypertension of 
high blood pressure) “Hypertension based on Diagnosis” 
 
 
 
 
 
 
 
Recoded into HTN (Hypertension_Diagnosed & Measured), where: 
1=yes  
 0= all others (no, don’t know, not sure, missing values) 
Step (1): IF  (A1014=4,5,6); HTN=1  
 
 
 
 
 
 
 
 
Step (2) IF  (A1014 =1,2,3 & A404 = 1); HTN=1 
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Step (3) IF (A401 = 1); HTN=1  
 
 
 
 
 
 
 
 
Step (4) Dummy variables with “0” indicating all other “Non-Hypertensive” cases 
including the system missing to avoid the unnecessary loss of cases. 
 
 
 
 
 
 
 
 
Diabetes  
 
A408 (Ever been told by a doctor or other health professional that you had diabetes (Other 
than during pregnancy)) “Diabetes based on Diagnosis” 
 
 
 
 
Recoded into DM (Diabetes_Diagnosed), where: 
1=Yes  
 0= Others (No, Don’t know, Not sure, Missing) 
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Heart Attack or Myocardial Infarction 
 
A413 (Ever been told by a doctor or other health professional that you had a heart attack or 
myocardial infarction) “Myocardial Infarction based on Diagnosis” 
 
 
Recoded into MI (Heart Attack & Myocardial Infarction_Diagnosed), where: 
1=Yes  
 0= Others (No, Don’t know, Not sure, Missing) 
 
 
 
 
 
 
 
 
 
Stroke 
 
A418 (Ever been told by a doctor or other health professional that you had a stroke) “Stroke 
based on Diagnosis” 
	
Recoded into Stk (Stroke_Diagnosed), where: 
1=Yes  
 0= Others (No, Don’t know, Not sure, Missing) 
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Number of NCDs 
 
New variable to reflect the number of NCDs for each respondent 
NCD_Number (Number of NCDs) = HTN + DM + MI + Stk 
 
 
 
 
 
 
 
 
 
NCD 
 
New (dummy or indicator) variable to reflect whether the respondent has NCD(s) or not 
IF (NCD_Number >= 1), NCD = 1  
IF (NCD_Number = 0), NCD = 0 
 
 
 
 
 
HTN_tt (Hypertension Treatment) 
 
New (dummy or indicator) variable to reflect whether the respondent (Hypertensive Patient) is 
receiving a treatment for his NCD(s), based on A404 (taking a prescribed medicine) 
 
A404 (taking a prescribed medicine to lower the hypertension or high blood pressure) 
 
    
Recoded into HTN_tt (Hypertension Treatment), where: 
1 = Yes  
 0 = No (including missing) 
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DM_tt (Diabetes Treatment) 
 
New (dummy or indicator) variable to reflect whether the respondent (Diabetic Patient) is 
receiving a treatment for his NCD(s), based on A410 (taking a prescribed medicine) 
 
A410 (taking a prescribed medicine for diabetes) 
 
 
 
 
 
 
 
Recoded into DM_tt (Diabetes Treatment), where: 
1 = Yes  
 0 = No (including missing) 
 
 
 
 
 
 
 
 
MI_tt (Heart Attack or Myocardial Infarction Treatment) 
 
New (dummy or indicator) variable to reflect whether the respondent (Diabetic Patient) is 
receiving a treatment for his NCD(s), based on A415 (taking a prescribed medicine) 
 
A415 (taking a prescribed medicine because of the heart attack or myocardial infarction) 
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Recoded into MI_tt (Heart Attack or Myocardial Infarction Treatment), where: 
1 = Yes  
 0 = No (including missing) 
 
 
 
 
 
 
 
Stk_tt (Stroke Treatment) 
 
New (dummy or indicator) variable to reflect whether the respondent (Stroke Patient) is 
receiving a treatment for his NCD(s), based on A420 (taking a prescribed medicine) 
 
A420 (taking a prescribed medicine because of the stroke?) 
 
 
Recoded into Stk_tt (Stroke Treatment), where: 
1 = Yes  
 0 = No (including missing) 
 
 
 
 
 
 
 
Number of Treated NCDs 
 
New variable to reflect the number of Treated NCDs for each respondent 
NCD_tt_Number (Number of Treated NCDs) = HTN_tt + DM_tt + MI_tt + Stk_tt 
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NCD Patients Data Set "2_EHIS_2015_Individual_NCD.sav" 
A new Dataset was created by filtering out patients without any NCDs (i.e. NCD_Number=0), the new 
dataset named "DHS_2015_NCDpatients," and it contains only respondent with one or more NCD (2,115 
case) 
 
Access to NCD Treatment [Among NCD Individuals] 
 
New variable to reflect the percent of treated NCDs out of the total NCDs a respondent has.  
access_NCD_tt (Access to NCD Treatment) = (NCD_tt_Number / NCD_Number)*100 
 
 
 
 
 
 
 
Access to NCD Treatment_Dummy (access_NCD_tt_D) [Among NCD 
Individuals] 
 
A (dummy or indicator) variable to reflect whether the respondent has access to NCD(s)’ 
Treatment or not  
**Access to treatment is defined as 100% access (i.e. receiving medication for all NCDs the 
respondent has) 
 
IF (access_NCD_tt <100) access_NCD_tt_D=0 (NO) 
 
IF (access_NCD_tt =100) access_NCD_tt_D=1 (Yes) 
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Inccess to NCD Treatment_Dummy (inaccess_NCD_tt_D) [Among NCD 
Individuals] 
 
A (dummy or indicator) variable to reflect the in-access to NCD(s)’ Treatment  
**Access to treatment is defined as 100% access (i.e. receiving medication for all NCDs the 
respondent has) 
IF (access_NCD_tt <100) inaccess_NCD_tt_D=1 (inaccess) 
 
IF (access_NCD_tt =100) inaccess_NCD_tt_D=0 (access) 
 
 
 
 
 
Out of Pocket Spending on NCD (OOP_spending_NCD) [Among NCD 
Individuals] 
 
A428 (In total, how much have you spent for care/treatment for the (condition's') in the past 
four weeks?). Recoded into “Out of Pocket Spending on NCD” 
 
Facility of Receiving NCD Treatment (facility_NCD_tt) [Among NCD 
Individuals] 
 
 
 
 
 
 
 
 
 
A427 (Currently receiving care for conditions in 428 in a government health facility or in a 
private health facility)?). Recoded into “Facility of Receiving NCD Treatment” 
Main Variable 
for Inequality 
Measurements* 
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Appendix (2): Average Monthly Out of Pocket Spending on NCD Treatment, 
EHIS 2015 
  
Overall
Governmental 
Healthcare Facility
Private  
Healthcare Facility
Both  
Governmental & Private 
 Healthcare Facility
Incomplete Access Complete Access
110.29 40.11 140.18 147.61 154.29 129.57
<29 66.99 41.43 137.01 104.2 204.35 123.79
30-39 119.39 35.3 190 102.53 259.98 158.72
40-49 80.8 15.43 98.3 123.39 111.56 93.52
50-59 133.93 52.24 154 174.52 155.87 144.11
Male 141.4 16.87 192.91 158.11 123.05 170.2
Female 93.47 55.18 111.38 142.31 184.2 108.01
Urban 128.28 39.57 162.16 160.92 118.77 147.8
Rural 93.29 40.95 118.44 135.94 197.89 111.1
Urban governorates^ 145.83 41.04 199.93 168.7 85.18 169.84
Urban lower Egypt 113.67 42.26 145.66 137.25 141.03 133.1
Rural lower Egypt 86.35 47.52 102.37 134.46 226 99.56
Urban upper Egypt 120.17 33.45 132.5 202.28 136.24 132.73
Rural upper Egypt 110.71 31.18 161.31 141.24 147.57 142.39
Frontier Governorates 84.27 1.64 117.96 87.08 446.01 89.06
Q1 (poorest) 71.27 34.82 81.34 182.04 198.58 86.07
Q2 95.5 22.11 136.44 117.46 179.52 117.87
Q3 98.95 65.74 122.3 128.33 190.88 114.29
Q4 99.28 40.4 121.69 173.47 150.42 114.77
Q5 (richest) 149.27 38.32 187.16 157.32 116.69 169.86
No education  94.67 19.1 113.61 160.53 182.26 107.16
Some primary 102.79 57.98 118.65 157.11 125.76 116.43
Primary complete 122.08 40.41 161.31 139.44 173.86 144.26
Secondary complete/ 
higher 111.86 49.98 153.35 137.97 109.04 144.6
Never married 60.74 71.45 89.17 108.84 44 94.97
Ever married 112.1 39.62 141.56 149.32 157.05 130.56
Not Employed 95.3 53.9 110.77 156.61 165.34 109.52
Employed 130.01 23.48 179.97 136.3 142.63 157.01
**P<0.001
* 1 USD =  7.6344 EGP (May 2015)
Variable
Region*
Wealth quintiles*
Education*
Marital status*
Employment*
Age (years)*
Sex*
Type of place of residence*
National*
Average Monthly Out-of-Pocket Spending on NCD Treatment
Facility of Receiving Care to NCD(s) Conditions Access to NCD Treatment
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Incomplete Access to NCD Treatment, Simple (Gap) Measures of Inequality, EHIS 2015
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Appendix (3): Incomplete Access to NCD Treatment, Simple (Gap) Measures 
of Inequality, EHIS 2015 
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Appendix (4): The Calculations of the Mean Deviation (MD), Standard 
Deviation (SD), and their, Weighted, and Relative Measures 
 
Formulas Used: 
 Mean	Deviation	from	the	mean = 	 y1 − µ4156 n  
 
 
 
 
 
Standard	Deviation	 SD = 	 y1 − µ 94156 n 
 
 
 
 
 
 
 Weighted	Mean	Deviation	from	Mean = 	 N1 y1 − µ N4156  
 
 
 
 
 
 
Weighted	Standard	Deviation = 	 => y1 − µ 94156 N 
 
 
yj : the rate in group j,  
µ : the population average rate,  
n : number of social groups 
yj : the rate in group j,  
µ : the population average rate,  
Nj : population size of social groups, 
N: Total population 
yj : the rate in group j,  
µ : the population average rate,  
n : number of social groups 
yj : the rate in group j,  
µ : the population average rate,  
Nj : population size of social groups, 
N: Total population 
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 Percent of 
people with 
Incomplete 
Access to NCD 
Treatment
Number of 
NCD 
patients
share (N) |yi – µ| (yi – µ)^2
MD 
(Mean 
Deviation 
from the 
Mean)
  Mean 
deviation 
to mean 
ratio
wMD 
(Weighted Mean 
Deviation from the 
Mean)
Weighted mean 
deviation to mean 
ratio
SD 
(Standard 
Deviation)
  Standard 
deviation to 
mean ratio
wSD 
(Weighted 
Standard 
Deviation)
Weighted 
Standard 
deviation to 
mean ratio
30.80 2136848942
<29 60.5 197672350 0.0925 29.7 882.09 11.70 0.38 7.92 0.2573 15.96 0.518 11.081 0.360
30-39 39.1 303349574 0.1420 8.3 68.89
40-49 30.2 640940410 0.2999 0.6 0.36
50-59 22.6 994886608 0.4656 8.2 67.24
Male 35.4 794370132 0.3717 4.6 21.16 3.70 0.12 3.47 0.1126 3.81 0.124 3.577 0.116
Female 28 1342478810 0.6283 2.8 7.84
Urban 26.6 1014042468 0.4746 4.2 17.64 3.95 0.13 3.94 0.1278 3.96 0.129 3.945 0.128
Rural 34.5 1122806474 0.5254 3.7 13.69
Urban governorates^ 24 402221753 0.1882 6.8 46.24 5.02 0.16 4.70 0.1526 6.61 0.215 14.193 0.461
Urban lower Egypt 28.4 328039058 0.1535 2.4 5.76
Rural lower Egypt 29.7 756997729 0.3543 1.1 1.21
Urban upper Egypt 28.4 276809570 0.1295 2.4 5.76
Rural upper Egypt 44.6 361116847 0.1690 13.8 190.44
Frontier Governorates 27.2 11663985 0.0055 3.6 12.96
Q1 (poorest) 42.1 297162122 0.1391 11.3 127.69 5.98 0.19 5.75 0.1866 6.76 0.220 6.413 0.208
Q2 37.4 415066638 0.1942 6.6 43.56
Q3 27.4 345498175 0.1617 3.4 11.56
Q4 28.6 452211318 0.2116 2.2 4.84
Q5 (richest) 24.4 626910689 0.2934 6.4 40.96
No education  31 551502223 0.2581 0.2 0.04 1.70 0.06 1.14 0.0369 2.30 0.075 1.844 0.060
Some primary 27.7 379229727 0.1775 3.1 9.61
Primary complete 30.7 895809189 0.4192 0.1 0.01
Secondary complete/ 
higher 34.2
310307803
0.1452 3.4 11.56
Never married 57.7 96910806 0.0454 26.9 723.61 14.10 0.46 2.46 0.0799 19.04 0.618 5.868 0.191
Ever married 29.5 2039938136 0.9546 1.3 1.69
Not Employed 28 1185114566 0.5546 2.8 7.84 3.10 0.10 3.07 0.0996 3.11 0.101 3.082 0.100
Employed 34.2 951734376 0.4454 3.4 11.56
Age (years)
Sex
Type of place of residence
Wealth quintiles
Education
Marital status
Employment
Stratifier 
Total Population
Region
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Appendix (5): Calculating the Population Attributable Risk (PAR & PAR%), 
EHIS 2015 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Incomplete Access to NCD Treatment, Population Attributable Risk Measure of 
Inequality, EHIS 2015 
Stratifier
Percent of Individuals  
with Incomplete Access 
to NCD's Treatment 
Population 
Attributable Risk 
(PAR) 
"Absolute"
Population 30.8
Age (years) 50-59 22.6 8.2
Sex Female 28 2.8
Type of place of residence Urban 26.6 4.2
Region Urban governorates^ 24 6.8
Wealth quintiles Q5 (richest) 24.4 6.4
Education Some primary 27.7 3.1
Marital status Ever married 29.5 1.3
Work Not Employed 28 2.8
Reference Group 
(Best Performing Subgroup per Each Stratifier)
^  Cairo, Alex, PortSaid, and Suez
Socio-economic Inequalities in Accessing Treatment of NCDs, EHIS 2015          63 
Appendix (6): Calculating the Slope Index of Inequality (SII), EHIS 2015  
  
X-axis Y-axis
Proportional 
Distribution of 
Population
Midpoint of 
Cumulative range of 
Population  
(X axis)
 Percent of people with 
Incomplete Access to NCD 
Treatment  
(Y axis)
Q1 (poorest) 0.139 0 0.139 0.0695 42.1
Q2 0.194 0.139 0.333 0.236 37.4
Q3 0.162 0.333 0.495 0.414 27.4
Q4 0.212 0.495 0.707 0.601 28.6
Q5 (richest) 0.293 0.707 1 0.8535 24.4
Rank (1) 19.342
Rank (0) 41.702
X-axis Y-axis
Proportional 
Distribution of 
Population
Midpoint of 
Cumulative range of 
Population  
(X axis)
 Percent of people with 
Incomplete Access to NCD 
Treatment  
(Y axis)
No education  0.258 0 0.258 0.129 31
Some primary 0.177 0.258 0.436 0.347 27.7
Primary complete/ some secondary 0.419 0.436 0.855 0.6455 30.7
Secondary complete/ higher 0.145 0.855 1 0.9275 34.2
Rank (1) 23.1883
Rank (0) 28.222
-22.36
Wealth quintiles
Slope index of inequality: absolute inequality in Incomplete Access to NCD treatment, Wealth based
Slope index of inequality: absolute inequality in Incomplete Access to NCD treatment, Education based
Education
Cumulative range of 
population
Cumulative range of 
population
Slope Index of 
Inequality (SII)
-5.0337
Slope Index of 
Inequality (SII)
y	=	 -22.36x	+	41.702
0
5
10
15
20
25
30
35
40
45
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9
In
co
m
pl
et
e 
A
cc
es
s 
to
 N
C
D
 T
re
at
m
en
t 
(%
)
Cumulative Fraction of Population ranked by wealth index
Percent of people with Incomplete Access to NCD Treatment, 
Population ranked by Wealth
y	=	5.0337x	+	28.322
0
5
10
15
20
25
30
35
40
0 0.2 0.4 0.6 0.8 1
In
co
m
pl
et
e 
A
cc
es
s 
to
 N
C
D
 T
re
at
m
en
t 
(%
)
Cumulative Fraction of Population ranked by education
Percent of people with Incomplete Access to NCD Treatment, 
Population ranked by Education Level
Socio-economic Inequalities in Accessing Treatment of NCDs, EHIS 2015          64 
Appendix (7): Calculating the Index of Dissimilarity (ID), and Index of 
Dissimilarity Percent (ID%), EHIS 2015 
 Index	of	Dissimilarity	(ID) = 	 12 S89 − S8;<8=>  
 
 Index	of	Dissimilarity	Percent	 ID% = 	100 ∗ ID S89D8=>  
 
 
 
 
 
 
 
 
 
Sjh : the proportion of the health 
indicator in the jth subgroup,  
 
Sjp : the population proportion of 
the jth subgroup 
Observed Share 
(Sjh)
Population Share 
(Sjp)
   2,136,848,942          657,314,177 
<29 197,672,350      119,669,178      60,805,813          58,863,365           
30-39 303,349,574      118,675,206      93,313,089          25,362,117           
40-49 640,940,410      193,679,962      197,159,102        3,479,140             
50-59 994,886,608      225,289,831      306,036,173        80,746,342           
168,450,963         84,225,482          26%
Male 794,370,132      280,950,054      244,355,480        36,594,574           
Female 1,342,478,810   376,364,123      412,958,697        36,594,574           
73,189,147           36,594,574          11%
Urban 1,014,042,468   269,750,864      311,928,690        42,177,826           
Rural 1,122,806,474   387,563,313      345,385,487        42,177,826           
84,355,651           42,177,826          13%
Urban governorates^ 402,221,753      96,603,300        123,727,071        27,123,771           
Urban lower Egypt 328,039,058      93,054,584        100,907,799        7,853,215             
Rural lower Egypt 756,997,729      224,775,485      232,859,389        8,083,904             
Urban upper Egypt 276,809,570      78,554,605        85,149,142          6,594,537             
Rural upper Egypt 361,116,847      161,157,670      111,082,828        50,074,842           
Frontier Governorates 11,663,985        3,168,533          3,587,948            419,415                
100,149,684         50,074,842          15%
Q1 (poorest) 297,162,122      125,012,558      91,409,773          33,602,785           
Q2 415,066,638      155,069,569      127,678,274        27,391,295           
Q3 345,498,175      94,677,157        106,278,382        11,601,225           
Q4 452,211,318      129,545,324      139,104,316        9,558,992             
Q5 (richest) 626,910,689      153,009,569      192,843,432        39,833,863           
121,988,160         60,994,080          19%
No education  551,502,223      170,975,990      169,647,102        1,328,888             
Some primary 379,229,727      104,894,000      116,654,515        11,760,515           
Primary complete/ some secondary 895,809,189      275,255,543      275,559,057        303,514                
Secondary complete/ higher 310,307,803      106,188,644      95,453,504          10,735,140           
24,128,057           12,064,029          4%
Never married 96,910,806        55,873,526        29,810,646          26,062,880           
Ever married 2,039,938,136   601,440,651      627,503,531        26,062,880           
52,125,761           26,062,880          8%
Not Employed 1,185,114,566   331,677,115      364,552,023        32,874,908           
Employed 951,734,376      325,637,062      292,762,154        32,874,908           
65,749,817           32,874,908          10%
Region
Stratifier
The Number of 
People in the 
Population
The number of people with 
Incomplete Access to NCD 
Treatment
Absolute 
differences in last 
two columns 
|(Sjh)- (Sjp)|
Total Population
ID 
(Absolute)
ID %
(Relative)
Age (years)
Sex
Type of place of residence
Wealth Quintiles
Education
Employment Status
Marital Status
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Appendix (8): Calculating the Theil Index (T) EHIS 2015 
 	t = p%r% ln(r%)+%,-  
 
 
pi : the proportion of the population in the subgroup i 
 
ri : the ratio of the health indicator prevalence in the 
subgroup i to the overall health indicator prevalence in 
the population 
The Number of 
People in the 
Population
Percent of 
population 
 (pi)
 Percent of people 
with Incomplete 
Access to NCD 
Treatment
Ratio of Stratifier 
to National Percent 
(ri)
Natural log of the 
Ratio Stratifier to 
National Percent 
(ln(ri))
Theil index 
components 
(piriln(ri)), 
multiplied by 1000
Theil index,  
multiplied by 
1000
2,136,848,942       0.308
Male 794370132 0.37 0.354 1.149350649 0.13919713 59.47465225
Female 1342478810 0.63 0.280 0.909090909 -0.09531018 -54.4352499 5.039402351
Urban 1014042468 0.47 0.266 0.863636364 -0.146603474 -60.0838155
Rural 1122806474 0.53 0.345 1.12012987 0.113444634 66.77031469 6.686499183
Urban governorates^ 402221753 0.19 0.240 0.779220779 -0.24946086 -36.58934812
Urban lower Egypt 328039058 0.15 0.284 0.922077922 -0.081125545 -11.48357164
Rural lower Egypt 756997729 0.35 0.297 0.964285714 -0.036367644 -12.42343398
Urban upper Egypt 276809570 0.13 0.284 0.922077922 -0.081125545 -9.690195265
Rural upper Egypt 361116847 0.17 0.446 1.448051948 0.370219169 90.59765811
Frontier Governorates 11663985 0.01 0.272 0.883116883 -0.124297717 -0.599176082 19.81193303
Never married 96910806 0.05 0.577 1.873376623 0.627742484 53.33410374
Ever married 2039938136 0.95 0.295 0.957792208 -0.043124427 -39.43100155 13.9031022
Not Employed 1185114566 0.55 0.280 0.909090909 -0.09531018 -48.0543954
Employed 951734376 0.45 0.342 1.11038961 0.104710954 51.785651 3.731255601
Marital Status
Sex
Type of place of residence
Region
Stratifier
Population
Employment Status
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Appendix (9): Calculating the Concentration Index, EHIS 2015 
 
The Concentration Index (CI) is computed as twice the (weighted) covariance of the health variable ‘in-
access to treatment’ and a person’s relative rank in terms of economic status ‘wealth index’, divided by 
the variable mean according to the equation:  
  
 ! = 	 $% !&'((*+, -+) 
 
 
 
 
 
  
Wealth quintiles* 0 0
Q1 (poorest) 297162122 0.139 0.139 125012558 0.190 0.190
Q2 (poorer) 415066638 0.194 0.333 155069569 0.236 0.426
Q3 (middle) 345498175 0.162 0.495 94677157 0.144 0.570
Q4 (richer) 452211318 0.212 0.707 129545324 0.197 0.767
Q5 (richest) 626910689 0.293 1 153009569 0.233 1
 concindc   inaccess_NCD_tt_D[aw=WEIGHT], welf(wealth_scale)
Concentration Index (CI) using grouped approach
as in Kakwani, Wagstaff & van Doorslaer (1997)
Concentration Index -0.12
Std. Error of CI 0.02 -0.056670 -0.180182
99.9% CI
* Calculated using STATA 12 
{concindc   inaccess_NCD_tt_D[aw=WEIGHT], welf(wealth_scale)}
Concentration Index: relative inequality in Incomplete Access to NCD treatment, Wealth based
Number of NCD 
Patients  
(In weighted 
sample)
Proportion of 
NCD Patients
Cumulative Fraction 
of NCD Patients
Number of NCD 
Patient with 
Incomplete access 
to Treatment
Proportion of 
NCD Patient 
with 
Incomplete 
access to 
Cumulative Fraction 
of NCD Patient with 
Incomplete access to 
Treatment
Education* 0 0
No education  551502223 0.258 0.258 170975990 0.260 0.260
Some primary 379229727 0.177 0.436 104894000 0.160 0.420
Primary complete/ some secondary 895809189 0.419 0.855 275255543 0.419 0.838
Secondary complete/ higher 310307803 0.145 1.000 106188644 0.162 1.000
 concindc   inaccess_NCD_tt_D[aw=WEIGHT], welf(education)
Concentration Index (CI) using grouped approach
as in Kakwani, Wagstaff & van Doorslaer (1997)
Concentration Index -0.01
Std. Error of CI 0.02 0.029321 -0.043515
* Calculated using STATA 12 
concindc   inaccess_NCD_tt_D[aw=WEIGHT], welf(education)
Concentration Index: relative inequality in Incomplete Access to NCD treatment, Education based
Number of NCD 
Patients  
(In weighted 
sample)
Proportion of 
NCD Patients
Cumulative Fraction 
of NCD Patients
Number of NCD 
Patient with 
Incomplete access 
to Treatment
Proportion of 
NCD Patient 
with 
Incomplete 
access to 
Cumulative Fraction 
of NCD Patient with 
Incomplete access to 
Treatment
95% CI
Yi : the health status of the ith subgroup i 
Ri : the fractional rank of the ith subgroup (for weighted 
data) in terms of the index of household economic status 
u : the (weighted) mean of the health of the sample 
covw: the weighted covariance 
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Appendix (10): Decomposition of the Concentration Index, EHIS 2015 
 
The method proposed by Kakwani, N., Wagstaff, A., & Van Doorslaer, E. (1997) was used to 
decompose socioeconomic inequality in ‘in-access’ to treatment into its determinants [33]. 
 
Equation: 
 
 
 
 
Steps: 
 
1. Regression: For the purpose of a simple decomposition calculations, a logistic regression 
model was estimated first, and the predicted probabilities (PRE_inaccess_log) was used 
to run a linear regression model, (PRE_inaccess_lin), which, in turn was used for the CI 
calculations 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
∑ ⎟
⎠
⎞
⎜
⎝
⎛
=
k
k
kk
y C
xC
µ
β
ˆ
 
 : the concentration index of the ‘Predicted’ outcome health indicator Y 
: the concentration index of the stratifier (socio-economic determinant) k 
: the regression coefficient for the stratifier (socio-economic determinant) k  
: the mean (average) of the stratifier (determinant) k  
: the mean (average) of the outcome health indicator Y  
Coef. Std. Err. Wald P.Value Exp(b)
Constant 2.03 0.00 24314404 0.00 7.61
age -0.05 0.00 95659203 0.00 0.95 0.95 0.95
sex_2 -0.23 0.00 2640564 0.00 0.80 0.79 0.80
residence_type_2 0.09 0.00 4307 0.00 1.09 1.09 1.10
region_6_2 0.16 0.00 807591 0.00 1.18 1.18 1.18
region_6_3 -0.37 0.00 72019 0.00 0.69 0.69 0.70
region_6_4 0.05 0.00 63702 0.00 1.05 1.05 1.05
region_6_5 0.05 0.00 1505 0.00 1.05 1.05 1.06
region_6_6 -0.45 0.00 237377 0.00 0.64 0.64 0.64
education -0.02 0.00 2821367 0.00 0.98 0.98 0.98
marital_status_1 0.19 0.00 610564 0.00 1.21 1.21 1.21
wealth_1 0.65 0.00 12107655 0.00 1.91 1.91 1.91
wealth_2 0.53 0.00 9798215 0.00 1.70 1.70 1.70
wealth_4 -0.05 0.00 55231 0.00 0.95 0.95 0.95
wealth_5 -0.22 0.00 712359 0.00 0.80 0.80 0.80
employment_1 -0.39 0.00 6950743 0.00 0.68 0.68 0.68
Dependent Variable: inaccess_NCD_tt_D
[95% Conf. Interval]
Logistic Regression  for 'inaccess_NCD_tt_D'
a Variable(s) entered on step 1: age, sex_2, residence_type_2, region_6_2, region_6_3, region_6_4, 
region_6_5, region_6_6, education, marital_status_1, wealth_1, wealth_2, wealth_4, wealth_5, 
employment_1.
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2. Calculate the average (mean) for the predicted outcome health variable (Y) and the 
stratifiers (socio-economic determinants) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Variable | Obs Mean Std. Dev.
Predicted probability of Inaccess to 
NCD Treatment (logistic) 2136848942 0.308 0.144
Age 2136848942 46.12 10.11
sex=Female 2136848942 0.63 0.483
residence_type=Rural 2136848942 0.53 0.499
region_6=Lower Urban Governorate 2136848942 0.15 0.36
region_6=Lower Rural Governorate 2136848942 0.35 0.478
region_6=Upper Urban Governorate 2136848942 0.13 0.336
region_6=Upper Rural Governorate 2136848942 0.17 0.375
region_6=Frontier Governorate 2136848942 0.01 0.074
Education in single years 2136848942 7.64 5.887
marital_status=Never Married 2136848942 0.05 0.208
wealth=Poorest 2136848942 0.14 0.346
wealth=Poorer 2136848942 0.19 0.396
wealth=Richer 2136848942 0.21 0.408
wealth=Richest 2136848942 0.29 0.455
employment=Not Employed 2136848942 0.55 0.497
Descriptive Statistics (mean)
Linear Regression
Coef. Std. Err. t P-value
Constant 0.898 0 311834 0 0.898 0.898
Age* -0.011 0 -284033 0 -0.011 -0.011
sex=Female* -0.047 0 -48037 0 -0.047 -0.047
residence_type=Rural* 0.016 0 1688 0 0.016 0.016
region_6=Lower Urban Governorate* 0.027 0 22394 0 0.027 0.027
region_6=Lower Rural Governorate* -0.071 0 -7551 0 -0.071 -0.071
region_6=Upper Urban Governorate* 0.007 0 5557 0 0.007 0.007
region_6=Upper Rural Governorate* 0.022 0 2293 0 0.022 0.022
region_6=Frontier Governorate -0.088 0 -14685 0 -0.088 -0.088
Education in single years* -0.004 0 -49104 0 -0.004 -0.004
marital_status=Never Married 0.059 0 32285 0 0.059 0.059
wealth=Poorest* 0.13 0 97448 0 0.13 0.13
wealth=Poorer* 0.104 0 87511 0 0.104 0.104
wealth=Richer* -0.006 0 -3871 0 -0.006 -0.006
wealth=Richest* -0.038 0 -21046 0 -0.038 -0.038
employment=Not Employed* -0.074 0 -73535 0 -0.074 -0.074
[95% Conf. Interval]
a Dependent Variable: Predicted probability of Inaccess to NCD Treatment (PRE_inaccess_log)
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. concindc   region_6_5[aw=WEIGHT], welf(wealth_scale)
Concentration Index (CI) using grouped approach
as in Kakwani, Wagstaff & van Doorslaer (1997)
Concentration Index -0.594
Std. Error of CI 0.015 -0.564 -0.624
. concindc   region_6_6[aw=WEIGHT], welf(wealth_scale)
Concentration Index (CI) using grouped approach
as in Kakwani, Wagstaff & van Doorslaer (1997)
Concentration Index -0.012
Std. Error of CI 0.216 0.411 -0.435
. concindc   education[aw=WEIGHT], welf(wealth_scale)
Concentration Index (CI) using grouped approach
as in Kakwani, Wagstaff & van Doorslaer (1997)
Concentration Index 0.186
Std. Error of CI 0.009 0.204 0.168
. concindc   marital_status_1[aw=WEIGHT], welf(wealth_scale)
Concentration Index (CI) using grouped approach
as in Kakwani, Wagstaff & van Doorslaer (1997)
Concentration Index -0.046
Std. Error of CI 0.060 0.072 -0.164
. concindc   wealth_1[aw=WEIGHT], welf(wealth_scale)
Concentration Index (CI) using grouped approach
as in Kakwani, Wagstaff & van Doorslaer (1997)
Concentration Index -0.861
Std. Error of CI 0.008 -0.846 -0.876
. concindc   wealth_2[aw=WEIGHT], welf(wealth_scale)
Concentration Index (CI) using grouped approach
as in Kakwani, Wagstaff & van Doorslaer (1997)
Concentration Index -0.528
Std. Error of CI 0.016 -0.497 -0.559
. concindc   wealth_4[aw=WEIGHT], welf(wealth_scale)
Concentration Index (CI) using grouped approach
as in Kakwani, Wagstaff & van Doorslaer (1997)
Concentration Index 0.202
Std. Error of CI 0.019 0.238 0.165
. concindc   wealth_5[aw=WEIGHT], welf(wealth_scale)
Concentration Index (CI) using grouped approach
as in Kakwani, Wagstaff & van Doorslaer (1997)
Concentration Index 0.707
Std. Error of CI 0.010 0.726 0.687
. concindc   employment_1[aw=WEIGHT], welf(wealth_scale)
Concentration Index (CI) using grouped approach
as in Kakwani, Wagstaff & van Doorslaer (1997)
Concentration Index -0.080
Std. Error of CI 0.011 -0.058 -0.102
95% CI
95% CI
95% CI
95% CI
95% CI
95% CI
95% CI
95% CI
95% CI
 concindc   PRE_inaccess_log [aw=WEIGHT], welf(wealth_scale)
Concentration Index (CI) using grouped approach
as in Kakwani, Wagstaff & van Doorslaer (1997)
Concentration Index -0.111
Std. Error of CI 0.005 -0.101 -0.122
 concindc   PRE_inaccess_lin [aw=WEIGHT], welf(wealth_scale)
Concentration Index (CI) using grouped approach
as in Kakwani, Wagstaff & van Doorslaer (1997)
Concentration Index -0.111
Std. Error of CI 0.005 -0.101 -0.121
 concindc   age[aw=WEIGHT], welf(wealth_scale)
Concentration Index (CI) using grouped approach
as in Kakwani, Wagstaff & van Doorslaer (1997)
Concentration Index 0.009
Std. Error of CI 0.003 0.014 0.004
. concindc   sex_2[aw=WEIGHT], welf(wealth_scale)
Concentration Index (CI) using grouped approach
as in Kakwani, Wagstaff & van Doorslaer (1997)
Concentration Index -0.030
Std. Error of CI 0.010 -0.011 -0.050
. concindc   residence_type_2[aw=WEIGHT], welf(wealth_scale)
Concentration Index (CI) using grouped approach
as in Kakwani, Wagstaff & van Doorslaer (1997)
Concentration Index -0.449
Std. Error of CI 0.011 -0.428 -0.471
. concindc   region_6_2[aw=WEIGHT], welf(wealth_scale)
Concentration Index (CI) using grouped approach
as in Kakwani, Wagstaff & van Doorslaer (1997)
Concentration Index 0.455
Std. Error of CI 0.019 0.492 0.418
. concindc   region_6_3[aw=WEIGHT], welf(wealth_scale)
Concentration Index (CI) using grouped approach
as in Kakwani, Wagstaff & van Doorslaer (1997)
Concentration Index -0.379
Std. Error of CI 0.014 -0.351 -0.406
. concindc   region_6_4[aw=WEIGHT], welf(wealth_scale)
Concentration Index (CI) using grouped approach
as in Kakwani, Wagstaff & van Doorslaer (1997)
Concentration Index 0.370
Std. Error of CI 0.025 0.419 0.321
95% CI
95% CI
95% CI
95% CI
95% CI
95% CI
95% CI
95% CI
Get CI for Y and each X (Stata)
3. Using STATA, the Concentration Index was calculated for both the predicted outcome 
health variable (Y^) and the stratifiers (socio-economic determinants) 
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4. Finally, Calculate the Elasticity, Contribution and Contribution Percent to the CI of the Predicted outcome health variable 
(Y^)  
 
 
Regression 
Coeffecient Average (Mean)
Copy from 
step (4-7) Elasticity (E) 
Contribution to CI
X Value (Elasticity * CI 
)
B  (Xbar or Ybar) CI B*Xbar / Y X Value = E * CI X value/ Y value
Probability of Inaccess to NCD 
treatment* 0.308 -0.11
Age* -0.011 46.12 0.01 -1.65 -0.01 13% 13%
sex=Female* -0.047 0.63 -0.03 -0.10 0.00 -3% -3%
residence_type=Rural* 0.016 0.53 -0.45 0.03 -0.01 11% 10.96%
region_6=Lower Urban Governorate* 0.027 0.15 0.46 0.01 0.01 -5%
region_6=Lower Rural Governorate* -0.071 0.35 -0.38 -0.08 0.03 -27%
region_6=Upper Urban Governorate* 0.007 0.13 0.37 0.00 0.00 -1%
region_6=Upper Rural Governorate* 0.022 0.17 -0.59 0.01 -0.01 6%
region_6=Frontier Governorate -0.088 0.01 -0.01 0.00 0.00 0% -26.97%
Education in single years* -0.004 7.64 0.19 -0.10 -0.02 16% 16.39%
marital_status=Never Married 0.059 0.05 -0.05 0.01 0.00 0% 0.39%
wealth=Poorest* 0.13 0.14 -0.86 0.06 -0.05 45%
wealth=Poorer* 0.104 0.19 -0.53 0.06 -0.03 30%
wealth=Richer* -0.006 0.21 0.20 0.00 0.00 1%
wealth=Richest* -0.038 0.29 0.71 -0.04 -0.03 22% 98.19%
employment=Not Employed* -0.074 0.55 -0.08 -0.13 0.01 -9% -9.35%
Y Value -0.11 100.00%
* significant CI at p<0.05
Contribution to CI%
Share of each variable
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Appendix (11): Summary of the Main Inequality Measures, EHIS 2015 
 
 
 
 
 
 
 
 
 
 
 
Weighted Mean and 
SD to Mean Ratio
Population 
Attributable Risk
Index of 
Dissimilarity
Theil Index
Slope Index 
of Inequality
Concentration 
Index
<=29
30-39
40-49
50-59
Male
Female
Urban
Rural
Urban governorates^
Urban lower Egypt
Rural lower Egypt
Urban upper Egypt
Rural upper Egypt
Frontier Governorates 
No Education
Primary
Secondary
Higher
Poorest
Poorer
Middle
Richer
Richest
Never Married
Ever Married
Not Employed
Employed
Socio-economic Stratifiers Simple Measure 
-5.001
19.8
-22.36
-0.01
-0.12
(84,225,482) ID 
(26%) ID%
(50,074,842) ID 
(15%) ID%
(60,994,080) ID 
(19%) ID%
(8.2) PAR
 (26.6%) PAR%
(6.8) PAR
 (22.1%) PAR%
(6.4) PAR
 (20.8%) PAR%
(17.7%) Absolute Gap
(1.73) Relative Gap
(7.92) wMD
 (0.26) wMD ratio
(5.02) wMD
 (0.16) wMD ratio 
(0.46) wSD ratio
(5.75) wMD
 (0.19) wMD ratio
Employment
Marital Status
(28.2%) Absolute Gap
(1.96) Relative Gap
Age
(37.9%) Absolute Gap
(2.68) Relative Gap
Wealth Index 
Quintile
Education
Type of Place of 
Residence
Regions
Complex Measure
Sex
Main Inequalities Highlighted
(36.6%) Absolute Gap
(2.31) Relative Gap
